var title_f8_63_9200="Diagnosis erythrocytosis II";
var content_f8_63_9200=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F65297&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F65297&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 576px\">",
"   <div class=\"ttl\">",
"    Diagnostic approach to suspected erythrocytosis in the absence of polycythemia vera-related features",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 556px; height: 602px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     PV: polycythemia vera; EPO: erythropoetin; Hb: hemoglobin; M: male; F: female.",
"     <br/>",
"     * PV-related features include increased red cell mass with arterial oxygen saturation &ge;92 percent, splenomegaly, thrombocytosis, and leukocytosis.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_63_9200=[""].join("\n");
var outline_f8_63_9200=null;
var title_f8_63_9201="Ebastine: International drug information";
var content_f8_63_9201=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Ebastine: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4303780\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Bactil (ES);",
"     </li>",
"     <li>",
"      Bromselon (ES);",
"     </li>",
"     <li>",
"      Busidril (ES);",
"     </li>",
"     <li>",
"      Clever (IT);",
"     </li>",
"     <li>",
"      Ebastel (AR, BR, CL, ES, JP);",
"     </li>",
"     <li>",
"      Estivan (BE);",
"     </li>",
"     <li>",
"      Evastel (MX);",
"     </li>",
"     <li>",
"      Kestin (FR);",
"     </li>",
"     <li>",
"      Kestine (DK, FI, HK, NL, NO, PT, SE, SG, ZA)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1978660\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antihistamine, Nonsedating",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1978663\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Symptomatic treatment of idiopathic chronic urticaria and seasonal and perennial allergic rhinitis",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1978659\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Oral: Allergic rhinitis (seasonal and perennial) and urticaria (chronic idiopathic): 10-20 mg/day",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821179\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1978662\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justified;\">",
"     Solution, oral: 5 mg/5 mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justified;\">",
"     Tablet: 10 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10374 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-61.234.146.186-4BCC47CC64-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_63_9201=[""].join("\n");
var outline_f8_63_9201=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4303780\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978660\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978663\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978659\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821179\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978662\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10374\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10374|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_63_9202="Small fracture fragment";
var content_f8_63_9202=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F77588&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F77588&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Small fracture fragment",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 540px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The x-ray appears normal and it is easy to miss the small fracture fragment on the dorsum of the neck of the 3rd metacarpal.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_63_9202=[""].join("\n");
var outline_f8_63_9202=null;
var title_f8_63_9203="Sea urchin and resulting wound";
var content_f8_63_9203=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F54699&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F54699&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sea urchin and resulting wound",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 282px; height: 370px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Black sea urchin (",
"    <em>",
"     Echinometra locunter",
"    </em>",
"    ).",
"    <br>",
"     (B) The presence of spines in a victim who stepped on the animal.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced from: Haddad V, Lupi O, Lonza JP, Tyring SK. Tropical dermatology: marine and aquatic dermatology. J Am Acad Dermatol 2009; 61:733. Illustrations used with the permission of Elsevier Inc. All rights reserved.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_63_9203=[""].join("\n");
var outline_f8_63_9203=null;
var title_f8_63_9204="Endometrial cryoablation";
var content_f8_63_9204=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F70561%7EOBGYN%2F61286&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F70561%7EOBGYN%2F61286&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Endometrial cryoablation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 434px; height: 363px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFrAbIDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKhuru3tIy9zNHEgGcuwFchrfxK0DTAcXH2hh/zz6fmaxqYinS+Jm1KhUqu0Itna0V47c/Fq8vHMei6VLKT0Kxs/8A9aqx13x5qgJjtHtUP99hH/8AXrD67zfBBv8AA645ZV+21H1Z7USAMkgVG1zAv3poh9XFeLt4d8W3wDXWpxRccjez0DwHqb58/XZcnskf+JpKvXe0LfMv6hSW9T8D2Q39mp5u7cfWRf8AGhb60Y4W6gJ9pAa8cb4dkgebq12T6gAVGfh3t5/te849MCrU8R2X3sf1Gj0m/u/4J7assbjKOrA+hBp25fUV4S/gi5gBNtrt+rdsngVVOh+ILRwYNdldR/fUn+tKdetD7K+//gDWWxltP8D6ByPWivn77X4wtc7buGfHYOVJ/OrMHjrxXZACXT7hlHXGJBWH1+a3p/c7g8pn9mSPeKK8Xt/i/LAwXUbRoyf+ekZXFdJpfxU0e7wJflJ7owYVazKl9u69UYTyzER+zf0PRKKwrLxVo15jyr6ME9mOK2IpopVzFIrj1U5rohiadT4JJnJOlOHxKxLRSUtbp3MwoooouAUUUUXAKKDSUrgLRSdqWi4BRRigU7gFFFFFwCiiii4BRRRRcAooopgFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRSE4GScCuZ8R+OdC0GNjd3iPKP+WcZ3H/61ZVK0KavN2Lp0p1HywV2dPVLU9VsdLiMt/dRQIP77Yrx67+InifxQzQeE9MeC3Jx9pfgAeu4/0qC1+HN5qs32jxVrNxdOxyY4SVU+2TzWHt6lRfuo/N/5bnoQy9Q1ryt5LVnReIPjLo9lIYdKglv5zwu3gE/TrXN/8Jn498S86Vp/2C2Jxvddn6nmu20bwvpWkIF06xhiIGN+3LH8TzWzHCoI4oVCc/4km/TQ3ToUv4cL+b1PNl8Dazqsm/XtbkIbqkIJP/fR/wAK6XSvAmh2AVo7BJJV/wCWk3zsfzrq1TnoPepVxjrxWlOhTp/CiamKqT0uVbexjhUCNFUDsBirKwDrgVIHGOgxSecBxxWpzuUmCxAdqGjA96DKM9eKjaZQetIFzDWj56AGoZI1p0lwuetV3mGMd/Wi5rFMqzxg5AArPmgRu35VoSSDp39arSMD2wKl2e50wujJmgAOAJMdiOapvHtbkuOO6VszdOMVQmjycjdn/ZauOtSXT+vuOuEmZNxEsoIcRv2wRj+dZVz4f02ZD5tjEhPVkXn8xXRsCpzmQZ7MuRVWUKx5K59siuCcXHVHRGRycvhWFR/od3cxHPGJNw/I0tqnibSmDWGpRzbeQspKEj09K6WWA53Dn3NRMpA7nHTHIrlm/wCaKNb8ys2GnfFjWNJkEfiTTHEfTzVGR9dwr0Tw/wDELQtaiRorpYy3Zz/WvM3TcCpUEHt2x9KxNR8OWMp81I2tJzyJbc7cH3HStKeMqU37smvXVf5nJVy2jV6Wfl/kfSkUscqBonV1PQqcin180adqXi3w6QbKY6jaqc5RtsmPdTwa7vw18XraeRbbVk8mfoQ42MPwNejSzNW/exsu61X+aPJrZVUjrTd/zPXMUdqztL1mw1OMPZ3CSf7OeR+FaOa9GnUhUXNB3R5koyg7SVgpKWjNW0SJS5pKXikAUUYopgFFFFOwBRRRTAKKKKACiiigAopodSxAYZHUZ6UoIPQ5qbp7ALRRRimAUUU1nVBl2Cj3NF7bgOopiyxsMq6n6GnAjrSUk9gsLRSFgoJJAA7mszUNf0rT1zd30EftuBP5VM6sIaydiowlN2irmpRXn+ufFDR9PU/ZyZyO5O0Vxl5408Y+IlcaPZfZbZ+FlY7AR65PJrk+vwk7Uk5Py2+87qeW1pLmn7q8z2XUtWsNMiaS/u4YFHJ3tz+Vec6/8ZdGtpfsuixy6hdNwoRSRn8Oa5S0+H9zqUom8U6rNdsf+WMRIT8T1Nd3oXhKz06NRpemRRYH3tnP50WxFXdqPpq/vOiOGw1HWb5n9yOLkuPG3jGTNy50qx6gNwT/AMBH9a1NC+HOlWc4uNQeTUbnOd0/3QfZeld69hHaReZqF1BbR9zI4H8657VPiB4F0YlbrWoZ5F/hiO/+VOGHpUXeWr7vc0+sTqLlox07RRtxW8UMaxxIqRjgKowB+FWY1Y42KSPpXl2qftA+GrXK6Tpl1eOOhICiuW1D9obXZ1I0zRLe3HZpCWxVvE00OOCxM/sW9X/w59BLbzsOIiKethORlti+5NfKuo/GTx3fZWO9t7UEf8sowCK5m98U+KNRyL/xDfMD1VZCBWTxkeiOiGUV5btL7/1sfZs32W2XN1qFvF67nA/rWXd+JPC1lk3Wv2SY6jzh/SvjKZJZmBubu6mJ/vSE0wWlvjBTJ9+azeNfRG8ckf2qn5H1vdfE7wFbHD63HJ/1zy39Kqt8XvACkkagzY9IzXyrHFCDxCpA9qmWOAjKwpjvkVDxs+hssjpdZP7/APgH01N8bPAcQ4luHP8AsxH/ABqm/wAefBKt/wAe18R6iH/69fPCxw45jQHHpSgKo+4ox0GKzeOmaxyKj3f3n0MPjr4MblLS8P1ixTl+OPgxwN1pdDPUGMf4189gAYJUHPbtUgEWeUU/hUvHVP6saLIsP1b+9nvcnxe8D3J+9dQMf9mqr/E7wo+PK1BsE4+ZMYrxBY4WJ/coT/u0LbWzNzBGT/u0fX5mqyalHZv7z23/AITvw7KxEes24z03cVKviPSZwfK1Oxb/ALaYrwqWxtCCfJXB9qhOmWjYxFt9xWbxXNv/AF+JX9lpbM+gYdWtXyY76BiP7soOKl+07wCGjcEdcg5r54OlW2coX3DjhiDT0tbiJAIL64T2Eh4qParow/s2Xc+gS6nkx8f7JxTGkVkByQP9oV4THNrUBHk6vPjsGOatR6/4rhxtvkkAHAYVDkn1F9RqI9lkEZB4Ye45qIBsllZWA/hNeVJ408SQqPPt7aUD04NXLX4jzR5F5pUhPQsjZxWTpN6rUTw9SPQ9JZgPvxsrf3l7VXutOttQjK3EMNyv+0MMPxrlLP4h6VIAJ/tFsx/vxkj862bPxFpd7j7Pe2rN6bwp/I1Fpwd0mZSp9xi6Lf6ZKJdB1CWJgf8AUXDEr+DV0mj/ABR1PRzHB4ktHjXp5jDcp/4EKqrcOvIJZfzqXzYpUKOo2nqpG4H8KqNRKV9YvutP+AYVaEaitNXX9dT1LQvGWk6uimK4RGI4DNwfoa6NWDDKsCPUV843/he2kmFxpEz2E/U+UfkJ91NWdP8AFXjDwyMmEX9ovJ2cnH06/lXo08bWj8S5l3Wj+7Y8itlUXrSdvJ/5n0PRXj+kfHPRZiseq209nL0buM12em/ETwvf48nVYVJ6B+K7o42i93b10/M82eBrw3g/lr+R12aKx08SaM4BXUrU55/1gqOXxVocWd+p2w/4FmtPrdFbzX3oy+r1X9l/cblFcx/wnXhzeFOpxD3PSr1n4m0S8H+janaP7eYAaFjaD2mvvHLDVo6uD+42aKiiuIZQDFKjg/3WBqTNbqonsYtNbi0VXuL22tkLXFxFGo6lnArn7/x74bseJdUgLeiHNZzxVGn8ckjSnQqVPgi38jqKKKK3MjyDx/4f1CbxVfXunaze2rzmMCJMFBiNR0/DNY66p410LcYLmLUIYhkgtsJPpg8Vv+NvEsVh4uu7WQf6sIR+KKf607Sr+21S3iZNuWOWHvXjVIUalWSW9+mn5eZ9RThONCDqRvGy/IyIvinr9ouNR0abdjtFn9Qaiu/i3rtwAmn6LKHx1MR/rXXz2EDLkjNUZLOKFQ4UAA962lhXH/l5K3qRBYV6umrnA6l4g+IGsRkfaDYxN2Q7T+lc1eaV4hdTJda5dEnsGJ/rXoGuatFaxyhSAVPFcRPq8k80q7iRuBArkqqnHR6+up7WDhdXjBJehBa6dryqDb67eL2z2Fb1jB41g2CLxFKDnuDW14eCOjh4SQQDkcitp50i27YnwPWrp0KbXNb8DDEV483Koo4ybQ/GeoTB77xC20jacFjx9OlS2Xw7MsgbUNXvbj0VcIP8au+I/Gv9ixMwsWmx2Vsc15pqvxz1uKcJp1hBZop+8wLk1rGFBP3Y3ZzuVXl00X3fke9+HPh5Y20YaKwjB/56T/Ox9+a29Sn8O+HIfM1zVra32j7jSAH8B1r5fuPiX4p1+3ZpfEs8adGigxHgfhzXOvD57maSRrmU8mSVi5/M1csWoaRiZwyytXfNUqK3l/mfQuu/HTw1pu+Lw7p02pTAcSMNkefqea87134zeMdY3Lb3EGlQnjbbLlv++jXnhjK9se2KQKSK554qpLqd9HKcPS1au/PUn1G7vdWk8zVdRvLyQnkyyk/pVH7LCnKxqfqKsrHubn8MdqlW3z3J9jWDm+rPQjTitEimSqD5cL9BTeSODirP2Q5zzTktcD7uaOZD5WVsEgZ6+opwU9+tXhAMcdaVLc49R60uYOQpCNic9adtJBznArRS3IGcEgdBSGD5j1B/lS5ilApCJthwDn0oWNwT61o+RheRkevrTkh6fL8tLmK5GUAGIOBkj9Kd8x6jcBWkLZSOFOP1pRbDPIJHp3qblKDKS7iPkHHSnDGfT+tW/I/urn29KPKGBhT9ajc0SK6jaDxjP60gJzjp7VbEBXrnFOSJScDknsaQ7NlTOT15pVGQPTpVvyFBAwW9j2pywAH29+tJlWK6J0HY9PWl2jJHf2q0ICfu42+tCQA4ABB9e9Ta5SK0Y+YBvw4qUphsZxn+H1qwYhjGMH1HU0CNVyGHH90d6GikxgTeAq4z/dppg+YAhd3oKtRqARtH/Ae4qTaGI3D/AOtU8pSdyg1pGxOUBx3HSqlxpNtLktGAT3xW95ZBBz+Pr+FO8odCMZ7dc01zLZicYvdHO21vqFi2dO1K6hC/dUOSPyNa0HjHxJYjFzFa3qjABZNrfmKtPAoGBx/sjrTo41kxhDnvgfzrRVJrfU5p4OjLW1jR074mWQKrq2mXNq56vH86/wCNdRpXjDw9fMPs+qQDfwY5coR+dcLNaQhCbmONUAzk9K5LWrrSmLJaWpml6bo/u/nWsHd7Hn1sDBbSPoF7DSNSixJbWdyp6EbWzWdL8O/D08m77O8DekbFRXz7btqUUm+3b7NtOQFc5rvvDWueJplEaNLMBgdSRW3NHY86dCcPhZ6F/wAK20wBvLuLkc8fvjxUo+HOmHIaW4fPOGmPFSaFd6yFUXpRQfXrXSLcKoHmTpnvXRCjTavJHNKdVO1zAj+G+gqv7yHcT6uT/WopvhpojMTb+bC3YxyEV0x1OyjB33C1Uk1q0yVjl/HNa/uErWQR9u3dXORl8D6xpz50jXLiP0V2J/UVSvrfx0Aqf2t5igdTKwrrr3VUaMiOcVkS6j5cW5pcnPArgqU6HN8KO2mqstZa/I5i08J69qt0w1fVZAnpHIea7TTPhtoltta4UzNjBMjbuaxv7ZUTB/M2gdMGrF/41jiiEatvYDtSpzw8L3RVShiJtKGh9C0UUV9GfCnzt8XY3/4TvU3y2P3WOOP9Ulc3oms3GmToS2UBwa9V+Ing9tT1y8vo3cNKEyFPoijp+Fea6n4V1GzBMZEoH8LDBr5jEU2q0n5v8z7fBY+lLDwpTWyS/A6J/He2I8ZwOxrC1bx1LNFtjJGa5C+S5tnCXVnOgP8AEq5rHuLyFZP9Tck+gjNCrVmrNnfSoYNe8bOoazJdyOGY5qkkkjOSM9apwi+uHH2S0EfP35Tz+VaH/COX0p3S3UhY8/IcAVhOSXxM6XioQVoI7Dw7rqWcJWRyD9a6S08TQu4BcEL2NeW/2FqUEZ8m43H+7IA1QA39txcwdDkmM/0rSliXFWhI4aio1ZXkj07XbXSdbgZJf3bnnfGcGvNtf8D3MZaTTpIryIdY3G1v8Knsb2R3Lxybj0Iz0/Cun0u9EieW+cHvXTDEKcrVEaxwqjC8JXR4tqGkpDK6vFJaTr26c0tulzaOuSZk7spwRXsmr6db3kRS6iWRT6j+VcVqfh1rNHktZFMA5Mch6fjW020R9XXxR/AyrO5guZFUSBSeqzDafwIrXGlSMFdImZD3TDfyrGe0RyA4MZ7Z6Gmol5ZyB7S4kQjoUbj8q5W03ZFL2i1i7m2mnkHAIyfXinxWTHIC8Cq1r4w1a1UJeW8F7H3WSMZ/OtOz8b+H5cDUdFkt3zjdCTipcZ9ilinH4okH2Y9Cv+FI1mONtdNpt14X1Hm21R4GJ4Sb/wCvWg3huOYhrS9t5M81m58u5qsZSe+hxZtOQHXoKVbP+78x9PSuum8K6pGxaJbeVT1G8g1EfD+oBRvsnz/dRgf1qlJdy1iaL2kc0tvx6HuaX7PzlgCO1dF/Y13/ABWNzz/sdKfH4fvZMCKzu846+UaqK5tivrFH+ZHNi3YkbcE+lSiAqfufNjr2FdOvhXVipKaddZ9RGatx+DNafOLCcD3GKv2M+zE8XQ/nX3nHeUSPU+vpSGJgBuyR7dTXb/8ACD64CcWMlJ/wg+tjk2UlDoz7AsZh/wCdfejiPILDOc4pRA3XJz6iu0k8GaymCdOlJHcCo5PC2qIMtYz+/wAvSl7CfYpYui9pL70ckITtJ5wetN8ruAMGugm0e5Q/vIZQf9w1Xl058YZXAPbYal02jRVoPZmM8HIOMkfpT/s/QnP1NaS2pH8LY7jaacLZAuPmznqVNRyFe1j3M0R45Gc9M4pBFg5JwT+taT24HGTn2Bp62qEZVgB3GDTUA9rFdTM8srkAkfzoES4wMjPX3rV+yLj5A7nuAhNOWwkb7kUxx2K4zUuKW7D28F1MzyDngcDtUgiOQT07HHNa6abdFf8Aj3RB/wBNH/wqrcLbWuXvdVgiXuseM/So5oLqZPGU1sQxW7EcqcHvUpsh8vzqEzyAaybnxLo9qh+yJPeuP7xOKyL3xXqlwhW1hitIyeNo5p+9LZfeZSxjfwo6uUQW+d/3VGS7nbiucvvFEcUxSy2zEcfIOD9TXOSwXl/IDczyS+uTgVfstKO7ESqIx95jwo/GrStu7mUqtSXxOxVvp7rU5t99IxQfdiU4UVJaWbXWYYWWEAHA2n5j6DHWtq20MzyjGWXP+scYGPZf6mu00TSIrFAwTdJ/fPWuiFNyepLTSuzD8N+ElHlTajuIHJV+K7T7ZZ6ZDshVEVey8VkaxfvEpRflHSuP1G/Yqxkfao6knoKU6/s3ywRUcMprnqPQ6i+8Vt5hEe41mT+J5cfNkfVq5SKe5vFzZR7Yzxvccn3Ap8GgPcybrieRgOpJ4Fcc5u96khe2pR0hC5sT+IZXJJYfgc1UOs3O/OJSvqFNLb+F1uHxEpMf97GKvQ+FJP8AVwXNwjn+4TisnUp9WJ41x2iih/wksqBk3Mfw5qL+17qbgbjnpk10lv4CuMDdd3G5jnDLya3NO+GEzFHnd9p7E4NNSi9IkPNIx1aRwUd1M3EhOT2B5NX9P0y8umLLZ3Lqeh6Zr2jQfh1axBCbZM+p5zXd2Phi2t0A2L9AK3p4WdXVI8vEZ409H9x01FFFfWHx5BNbpKSWUEmsTVNGjkQsFG4V0VNYAjkVzVaEZ7mtOrKD0PM9V0AFGPlqw9CK4zVNFgwWW3XA68V7heQIUYMODXHa7p4jYyxKCvcevtXgY3Bcq5onsYXGu9meU22lwrIU8sLnoRVhtPkt84G+PuO9bWp2y2zrcQf6vPKHqpqRGSZUwRkj/INeLJNOzPVdZtcy2MVbVGjBAyD1PcfWqF/pEynenzoa6ie3WOTdH9zHzClsWDMYmAZT92ktGCqtao8m1/R5IJUurbMUoIzjvXWLpEkVnbX0SkrIoLLiuh17RWvpIYYU6tyR6Vv/AGJYdOWBh8qDaBXtYGDre7L7zSGL5Gmuu6OOjhWaHrwOg9Kx9TslcOjoGQ8EEcEVtXSG2uGCZCZyMd6rTAzIwx05Fd8E2uWW6PQpSad+jOCu9JFsxaNTNb45hJ+Zf90/0qlNZlYPOsmM9sPvYHzIfQjtXYXKFCeM1kzQPDcNdWbeXc4wc/dkHowrnnG50yofapnMbhKh54+nNIIYpB8yrkcdK1ryxW/D3GlR+XdIP39mev1X2rJt5FmB2EAg4IPUH0NYtW2M4y5tHuQvYwtJ/qhx3FIts8WDDPPH/uuRirygnO4YPalUFeVAJHajnY3CL6CW+pa5bt/o2q3QPoWzitKHxb4rhO0agsg/24xVPlRkocnqRVi2QStwcrnn3qZTXVIh4eD6HR6P8QvFFqeYdPm46vHzXZaZ8UPEgCeZplgy99pK1xGl2mSGYA57CuhtrbBG1fwqIYiUdI6HDXwlB7xO2tPihfuf3+jIMf3Za0F+Jox8+kSfhIK4LyiuDjApTH83cCtVjKvc4Xl+HfQ9CX4mQEc6XcD/AIEKUfEy0H3tNu/0rgYoHkkCIpZmIAA712Wn+Abie286abyyRkKBW1KviKztDU562FwlFXqaF7/hZlhgZ0+8/IUj/E3T1XP9n3h+gFcbrejXGl3JimHH8LAcGs4QOM5qZYurB2luXHAYeceaO3qd63xL0+Tppd2fqorPuviJp7qf+JFM/wBdorlxBKR2x6VH5EmBkDFZyx1Q0jgKK/4ctal4409t2PDdyrdisoFctceNZEfEehy7c95BW1PZ7gAyde9Y15pm3AAYewrmnXcndo9ChRprRP8AEqnxzc8mPQZc+8gpv/CaaryIdBQH1eWhNJk3H53Gat2+ks3zByx9zWbrR6L8zodGmupnSeK/EUhJi022iB/vPnFUpdV8WXQ+a4t7YeiJzXVro78bs49qkOlHZz1qPa9oom1JdTg57bV5z/pOozS+oVsCq6aIFctKC5Prk16L/ZIC8jtnpRJp5WJsAKP7xp+3lsUpQRw0ellV4QBTxzxUUlrFAu6QDjgcfe9gK3tWlS1XjMkjcKDyWPoBS6bYHTwt9qYD37DMcR5EI9T71cHKWr2NObpFalCDSisSz3ysm7mO26E/73pVuNN5XeFO0/KgHyr9BRPO00pdyWJPU1PYoZJVAXv2rqp6M7YYf2a5p6s6DR7EykMw4renhWK3x7YqfR7URwIGGOM1NfQl87fSvQVoxuePVr89TyPMtcLtcMASee9c1Y2ba3qExbItLc8j+8a9B1XTCuZCOeRXK+GnNqb3T5EWOd3zz35yMV5NZyipTW524irz0lGOxpQ6dsSJEUgPxwO1bltoizLGqKQnX8K27Cxhlt7M7iMghz+FdNbaelsu3bkeWADXnpSnqePVxKjotzH0/wALl7fc77U7ADrXQWumxWkYjt4lMpHLY5rbs0R0VVIO0VfiiUMMgD1969SjhI2TR5FXFzlpIz9N0lI/3so3TY6mtyy0wEiSYA+gqa2RNwJP/wBatJDkZFerQwsFpY8+rXkxI41QYAqTFAor1IwSWhyt3CiiirEFITQTUFxIFXk496yqTsNK7IryRduMiuc1HG0gfMrdRV+6nVuN1Zs80QB5GcV5ddyqaJHdRptHNX1tiQoyg7vyrIt7CSBnjjUsrHIJHQ107sN+cbj6moX8zJwQAOeBXlvLak32PVpzklYq2+nlULTdT1plvbQwOXI3Y6Ac4qxNcww8zTIAOxOaxb/xTp9sCIm8xh6VvDAUqf8AEkbU6NWp8KOi3x/fcBF/WsDV9WiXKxnjGAM1yWreMHmyFBVfSucuNbaRuDj610RxFGkrQPUw2Uz+KZ0N9fCSVNvrTrdwX29cjH0rlor/AHn76VtaZOR85KHjgZ61McRGUj0Z0OSNkOv48E+1Y1wNp55Fa97cq/Byrn16Vl3Q2n1FKck9jehe1mZdwjLMtxbt5d0nKOP5H2qpqNj/AGvC+p6ZGIdUhH+k2w48z3HvV+QiqrPNbXKXtnkSpwyD/lovpWKbKxOG9ouaO6MiGVLyBZIW5HDKf4T3BqzC4z7r0NTeILJIdmu6WubS4IFzEB9xv73+NVwCwBONnWoklbTY5Kc+bR7otbt5G3qRzVq0RS2XG3sMd6pxNtCgD5W5J9K1bBVbPR8HC1zz0RUtjpNNhACnFa8KMG5zjtVCzVgqgnpzmtaNR1fJbrkVmjzaj1HRorcsM+1WFjQngYx69KSJWzkHBPpVxIg3+sU5PUj1qjmlI1vB9okurKWAO0ZAr1SQBI1UD5RXm3g9BHq6bR2616TcDKiveyxfuX6nzuaSbrL0OS8a2SXmnNIg+aP5gceledrbbyMEHvjvXqmpLvsZlPGQR+lcD9iYDle/auXMoe+mjsyyram4t7GY1o38J6UnkEDEkZ+tbkNowIw2R6EVcitBjBWuBU2zulXsYCaekgG3cPqKhuNFD4xux646V2CWQXov5UslmUyUGSe1X9XvuZ/W2nozixpUkS4GGx6jmnx6YH+bZtYeorrvseecUJZ5yW4UdqX1Qf1tnOR6dgcDHvQ2nBRwuT6966k2xVeVH+FVp7bcM4OT2Hf61TwySJWIbZzMlsETdj2PoK5/XrlLK2eVgCB3PQn0Ars9STYo3ADHTHSvP7qWPUdWknnANhZnIB6O9c7ppysduHbmZmn2X2VTquqqGvJBmGM8+WKy725aeV3JJZjyas6vqD3c7MxIyenoKzCwyQc1pFdT6TCYfkXPLccu5yMV1nhnTy8iSMOM1z+mRrNOuBkV31lJBp9qGkIXA4zWkdNWRj63LHkjuzSeTY5DEADvThd24GGfJ71wPiHxRCszP9oRFbgAnn8q5W58XMznYLiQDpsXGa2deW0UeQsPC15ySPY5msrlcNtANZtx4d0q9cGQL5nZxww/GvJD4nu2O4212Fq3b+MDGVJkkX138Vi5zvdxL9jBK0ah7BYaVPaII7a+Dx/3ZVDfrXR2v29IlVooJhjGd2K8VtPGRyD53H1rotP8ZzgKVkyPrURlTTu42OWrl0pq8WmeoLc3EJ3NZyoP9j5hVu31u2Y4lco3o4xXC2njVzgMR+NbMOv2t6u24jjYHv1rohKG8JWPPq5fUXxRO8sryGUApKp+hrYhlBHUV51bxadJzDI8Enqjbf0rUtXvoAvkXizL6SDnH1rtpzqRV7X9DzKuEt/wTuVIPSlrm7LWnT5buIr/ALQ5FbdvdwzqDG4Nd1LExlo9GcFSjKG6LNFFFdZkZ17e+RM656f4Vi31+Xyd3FZ3i2/eDVp416Db/wCgiuWvNRmdTzXnVa6jJo9vC4Lmipdzfu7tF5d/1rLn1i1h+82cVy93czuOp+maxbuUjlySSfxrlni2tj2qWBil7zOovvFiplYFGfU1zmoeKbpg2Zdi+xxVBNL1PUMi3hMcZ/jfir1p4Ii+/fyvM3cZ4rz62MfVnSnhaHS7OXvfELTSFUeSd/7sYLVVEWuXj/6Np7Rg95TivT7XR7SyXFrAie4HNTtBkcHn1rhli10X3ieYS2grI8uPhHWbkEy3UcX+6M00eB7kD99fSE+ten+UUGGB+tNe23qTHg1n9bqGTxVR7yPMR4MuFYbL+TP4U19D1ywG+2mW4UfwNxXpMtljO1TxUQiKqeMjvSWKn11HHESWqZ5ja60Wla2vFe2uQfuP0P0rSSUkDcPlP6Vt+LfDFvrVk20BLheUkXg5rhNCubmG7m0rVTieP/VsRjcK7qVRVI80d10PUwmMVR8k9zanAzkD8ahyM8VPg7drcsOKjIrffU9aO1ibSWjiuJra5I+yXY2lG6bz/jXPzWcmmanNp85yifPGx7r2rWmQSRMv8R5U+h7VJrcZ1Xw7FqSKft1if3g7lf4h/Wl19TzcVD2U1URmQn7wY4UnpWrp58vOOx4rFjYOqSxtuVhke9adtIeh544PpWFRaCaujs9LIcAseg/M1vwBXBB47muR0uYAKrZ5FdPaS5wpyR61gnqebXg0zThTBDEcHpV6MlOozVa3U7hsOR3q9GFI9AK1jqefNmr4e2jUomUYP6V6JOMxivPNEGy9iI9ea9FbmJT9K97Lf4bR4OY/xE/IxrxQ0UinGM1yqwY6c81104H7wY9K5/y9sjEdieaWNjdxY8HKyZFDGjHHG6rkUIB9R6UscS7skDNW4U9awhCxvOZGkGGyP0qXyeuanVMU/aFHOK2UUYuZVSAHPHFOW3A5I47CpFY5+Xge9So4cncelaKCsLnZReLbknGfSqFyvBbOF/nWzcKMFm5H+eK5rXLsRo5LbUCkk+grmrtQRvRvJnHeM9UdCltbkG4nbYgHYd64fXZ1tIYrCFslfmkI7mrVjqLXt/qOtXHFtGDFb59uprl5ZzcSyTvkNIxbn07V5u+j+Z9dlmGu1foI77vmPWo1yW5OKMgsDnrT4155/lQfR2sa+issL75NuBzzWR4k1+51G6+x6c2EQ4kkHb2HvUWr3Zt7Xy4j+/k+VR71Y0XTUtYBgbnP3j3LGpnUUFc8THyXNyrcpWGgK02+RQ5PduTXQ2mkAuEijXcewFa+l6YWA3Eepz0FaYKoTDYqdx+9Kev/ANavOqV5TerPLclHSJkPo9rZR4umDSnkRL/Wqz+HYbr5rmGG1i6jcPmI+ldPBAluR5CC4vDwZHGQtXodLjX95dMZZjzgc0oyktUYSrW3OJk8I2Emz7LFIw9WAA/CoT4KnjZWgLxoP9rjNeowWE7hSkaW6Du3Jq3HpEcnLtJMfQcCtoe27mDxSieQHRtVszlHEi+jDNXLO4vLcD7RaOCOcx8166ukDCqsESY7tzTm0FCcl1+ipW8Y1OqKWZNaXPPrDWUYhd5Vs9GGDXRWd+64ZJGGfetibwtaNz5bHPfbVc+FAvMEkiN6EV1Q510E8bTmveRds9XY4EuHFbVleQsQysUz6dK5pdIvITgqJAPQYq/awOjAMrxn0YV2060npLX1OWrGjP4WekUUUV7x84cJ4tsxJq00mD8wXp/uiudl06ZgfKgZvduBXqlzapK24qC3qaqvZL/drzK9BuTaPUpY+UIKK6Hlg8NXVy2bmQIv92MVo23hi3tgClvub+83JrvjaqB90Cong6gjiuKeDvuy3j5yOT/sthxwB6CopNLboM11bQ+gqFoufu9KwlgoiWJkcsdOI4KE0q6dGq7jnp0xXRypn04qtJGp6g1zvCxiaKu2YX2JWHK5/CoZdPjwcjYexFbci7OFFVyhcEMQRXPOgtjSNVmHJaEAbuR/eFVrmzKnOMZ6N61umAxk4JK9xUXl5z5fQ9VNYOlY2jWOaltwykrw3df6ivOPH2iNIft1sP8ASIfmBXqfUV7Bc2GVLKDx+lc5rVksttIcAkA8UoN0pKSOujW1umeaaZci8s450xkjBzUki4GeorL0oGx165sG+WOQ+bFnp7itidSoPNerbS62PrcPV9rFSK2Rjjjireiyi31HZKP9HuhsYdt3/wBeqZJGR1oflQO/Uex7UnqrGtal7SFjPubJ9M1a509hhFPmQn1Q1ctyVUMACT1NWvE6teaTZa0gIktT5cw77T1/Ws+3kDAlOVIqKmq5jyqT05H0NvT5hkEHDHsa6bTrkBwxO4DjFcXbsBkjJ4wPUVsWtzsWMEkgfxCuSd0xVafMjv7OX5NwcbR1xWvA25QW/MVxlpdElBuGTySO9dLZXilADw3TPrVU59zxq9Jo6XTWIuI+mM9RXoSHNuh6cCvM7CX9/HyByORXpNud1khH92voMtleMkfPZirSTKM/35KyGGJX471q3BCytn0rJndRO+ema2xWyZlhepIAAwOBViM7ehqirAtkHipo5snBrmjI6Wi8GB+lMuDhQM81Gr569Kgml3Ngdq0TM7E4bCmnWh3MT2HSqEkuFODVnTh/o+7PWtLitoSXsqqjc4wK8r+JGoyppf2aDP2m8fyYgPU/4CvRdWkUREZ5b+VeS6tepe+Jp7xvmt9OjMUZPTzT94j6DivOxU05a7I9TAUuaWxy/iYpZ2FnpFucYUB8eg6/maw+BkCrFzcfbLma5PJc4Un0FVyuTmuRbH3eDo+zp+bEUZYe1W4wApZjjAzk1FEpzzVXXrk2+nlEH7yY7FHc1Sjc1rVFCLk+hW0iL+2NZluXJ8mH5Yh6nua9A0zTgSCx4HoKxvB2nGKyjDrhiMdOgrs7a2kbhflAHLHsK83E1Oedlsj5etVcm5Pdi+UzAQwjCLyxq3aWBchUDY6kjvVuwsvNA2kpbj+I9WNb1vakgADZF6Dqayp0XJnnVa/Loila6co+VRlscnsK1bSyhgzgbnP8XpU8YAG2NdiDvU0cJIBk+VP7vc/WvQp0UtkcE6je42K2UtuGXP6VdjiG3BOPZRUkcZKYHyKOnrV2CNdoAHPrXdSoo5pzZBFAM4CfiasLbnPJ4/KrUMB6k/lVhI1+tdsKKRzyqFZLfGKlFurA/LzVlUPHAp4XFdMaSZi5sqCzQj3p62iZ5AP1FWgKWtY0ES5sKKKK6iApCKWik0mBGyAioXjAPSrVIRWMqZSlYz2jyTVaZODxWo8QJ4qvLH1yOK5p0zWMjJdRjHQ1Vlj4NassQ61Rni3A5+lcdSnobwkZUiSRklhuXv6iqzqHBKHDVpujr3yPQ1SnjV2JwUcdxXnVIWOmLuUXZ0bEo47MKjZ8nD8ZPDCpppNjbZRuU9x0qF4sfNGd0Z/hrmkuxsvMcNwOSfxHes/UrVHUyRKM4+ZPWrUL7R8oLJnlfSmyOMho+nr6VDs1YuLcWeG/EW1TT9XtLy2BCq276DuKsTMJYlcEbWGRXU/FDSPtWlSTwIMocsPSuB0OYy6aEJy0Z2/SuuhK9Oz6H1WVVeeNiVx85oU56cU+XORnrURb0was97dGxorRzC50+cAxXSHg9M4rlbFXs7iawmz5tu+36r2NbEUjIyyqcNGQwxTfGsPkXVhrUODDOBFKR+hNCWvL3/M8jEw9lV5u4tucyZHDfzq3C+JDjAIGSD3qhCdoTJ46g1dQ53hwDu6NXJNCexs6bPtQsv38/dPSugs5yuATg9welcpACmNx6cgitqymYv8AP8y4xkVh1OOtC+p1IvGjtJjExDqjEeoOO1d78KNem1z4e2N9eMGmVSkj+uD1rzKPDI4JJBUjH4Vp/BSZpvg3qsILBoJpkHPoxr38l97mT8j5TOVyuLXmY3xE+JmoR+Irmx0qUQ26wthgvzMcHnNdj4T1GS/8OabdyuXkmgR2Y9SSOa+evF8jf8JXBnIDRkH34r2r4WyF/AOiFlwfs4H5EivRzWmqcYtHnZXNzcrnbrL0xxVmNunNUE5YVchK5ry4M9OSLW4BCfQVQ848kmn6jcCC29zxWQ1wdvXFbcxCjcvNJvYKO5xW2p2QKgPtXPaVma8BPQc1sXsqxRO+egwKtytG4uXVI5T4ga3/AGZpE80ZUzufIgX1Y15XrTNpmiQ2YbdPN99u+Tyxrf8AEkzat4uWPcGs9KTc3oZWriNWu2vtYnkJzFF8iDsT3NeZU96X4n1WU4Xa5XGEUL/COKVByagYmrEPUelR1PqrWWhPEpOKyth1HxNDEpzHB1HvWtI4igklPRFJo+HtiZVmv5uXlbINKpPkpuR4+ZVbRUO53uk2e9gsfy9Bz2FdDBarM3lAkQry5/vmo9Etz5fTBI5PoK27aJSPlGEHQevvXnU6blqfLYitrYfbQBtrMMRoPlWriKW6jA7Cnwx5QZ6GrKRgkADnqK9CFOx58p3GxQ5IJ5bsKvRwnI/ib9BRFDtAwee5q3EMDbGOnU12U6Xc55TFSFVwXO41aRecBQB70yMKpHBLVZSMkcnaPSu2EDnlIkjQYyTUwFNRAOQKkrshAwk7gBS4oxRXRFWICiiirAKKKKACiiigAooooAQio5FytS0hFZTjcaZRlj4qjNFj/Gth1BFU504b0rjqQNoSMiRMDI61UkXOcgY961JEGOnFUp4sZ44xXDUgdEJGW9uufl5z1Bqk8RiJMYPuua02Ug8D86jmTKg9/WuKdNdDpjIy3VWPmw8N3Hr7UwANkqPqtWJoirbo+D3FQMu0+ZH+Irnce5pcydTt/PilhcZjdSDXiFtbNpuu3lo56ucV9AXcW5d689+O1eTfErTzaapbapEmFc7ZPY0UXyScX1PZymvy1Un1MeVeTzVUjnp0q82HUMvQjiq0i7c9M11bn2MWLGccitextF1fQ7vSpOuMxZPQ9qx0PUnr2xV7TLxrO9hk42khW+hqXfdbnPi6XtIPuc/o8kjW7QXAxPbsYnB6gite3fa4HUY6GjxjZDTdeh1KPi2vhtkHYOO/40yM5ZCMZz1qK0ftLZnm0p80ddzUt2ZSAORt5Fa1jwy+U4x1ZTWJaSZfpgmtuxG4lwcMeBXE73IrbG0lx9lhecLvaFS5jPRsc4rtPhhJo7+BJbixiuLW31cNcNC+G8pmzkA+ma4Y/PbSow+ZkIyPpW98IH3fDjTE/uK8f5MRXs5TUcFJx8v1Pls3gpON/M5vWND8FHxTai8vdQnuYiAIVUIjH0Jrc8I68b/XNb0qO3itbHSGjgtYYxwqFc8nuc1534szD48Zh/z1Q11PgkBPiL4rjzxJHbzfmCP6V34urOpB8z/q55uEpxhP3UemROSR2q4h4xmqEfsKlurhbazeQnGB+Zrz4s9CSM3XL/dOIlOQtZouie/I71myXLSyO7HJJqS1BmmWNOSxxV31KUbI7Tw8pFu0796peLdWTTdMnuZDxEhfHqewrWjQW9lHGOAF5rzbxzdf2hrFnpJJMWftNx7KPuiitK0bFYWl7WoczPdNpvhmSST/AI+7lmmkPdmboPwrlEUxxKvBPUn1PetjxXdJdaituD8kJDkDpntWQ5yeK473Vz7vAUeSN+40HJzirdspJ6detV4xnrV+BRgUJHbNmb4kdvssVpEcPcOF49O9egeFtMWCwtbdQN2BnFcJp0Dap4oYqf3dr8gPbJ5NewaHCIijDBbGAPauTGT1VM+UzCtzTb7aHR2dqsNusY7jJq3BCOuKjiBwA3WrcI9OtbU4JWPm5ybJUjGRVtEwajhXGCTVhFya7IIwkyRVJGM4zU8MTngHatES8jir0aggV2QhcwlKwsMYwNox71ZVAPrSKvFPAxXbCByylcUUtJS11JEBRRRVWAKKKKYBRRRQAUUUUAFFFFABRRRSYDTVeReuRVmmSDIrCcSkzOnTj2qg68Z7VqzJxVGVcVw1Im8GZFwpDZHFVXycqefStOdB6VQkTk4riqRszpiyu6llGOvrVN18piwHynr7VcyRwelMkUEZUfnXLKNzZOxUC4JH8J5rlfGmmLfaVcW7KSSMofeuqA2sVPSodQh822ZepHSuecdLrdHRSqOEkzwjSn3WxjbiSJipFOmHPvVjWrf+zvEsg2bI7jJx2zUUqnkmumMudJo+9wtX2lNSKyjrTxg8HnPWmYx1BoXk8D61XU6mro35I11/wxcWEhBnjGFPcMOhrldKmaa2AfiaPMcq+jCtrRroWepxsxxHN8jf73Y1neIrcaZ4lMiDbb343DHaQf41LV04fNfqeLOHsqr7MsRucDcenANdBp0m1Ru7D865tT8w29CeRWnZS7VIb7hPHtXHUQVFdHXQMCnB7Vr/AAZJHgjyuT5V3cJ9PnNc5ay4Awcqe9b/AMGWP9iavDn/AFepTfhnBr0MrfxL0Pmc2jblfqcD8Qv3XjRnPcoa6Pw3mH4qan6XGmQyfkxFYPxVTy/FaNgfMg5/GtjSsp8UrB88TaQfxww/xr0a6vB+n+R5FB2qL1PT4iSQOlYviW+DyLboeF5NaV3dLbWjyEjgcVxUsrSzNK7fMxrgjselbW5KM10nhSx82X7Q64Ven1rn7GFrm4SNRyTXoVvGtnaxwoMHGK1gtSJy0sivrd9HaWUs0zBUUEk+w615DBeF4L3W7s4ku2LKP7sY+6K6f4j3puWt9It2w1yf3hHaMHn8+lcN4qnXbDYQjbGACwHTA7Vy1pc0rHt5Vhr2fcxC5keSZ+Xkbcf6U3n0oJyTQmSR71DPsYx5VYniTgZHNW5HEFrJLx8qk81FAoUDPJqPUiZZLe2Qfebe/wDuiqTtqcmKq+zpuRteALIx2m9k/fSEs59Sea9S0e3SEB5j83auS8PRJDCiIMkfzrtdPtjjzJTzjgGvNjepUcmfGYqeljVTJAK96tRgCq0fGKmjIJr0Yo8pltJCTirMY6Z6mqUY6EVet1z978K6qSMpF6ADg5zWhDyKowIBitCIcV6FKJyVGSAU4Ugpa9CEbIwYUUUVYgooooAKKKKACiiigAooooAKKKKACiiigApCKWkNRJaAV5hgVQuB2xWpIMj3qjcLxnpXHUibQZkzcHrnFUpeT7e1aUicnIqlMvU1w1YnRBmdIPm47Uxm7VYwPxqtKMPxiuKSN0yNkDc+lROMrgmpifm5FQMMNn1rJmqPNPibpD+SbuEbmT5xgdPWuQt3FxAkg7jmvatas0vbCWMgZI4rw62U2GqXenyAgK2Uz6GlS91uJ9VkmK5k6bJJM5PGKhBwetXJlGKp4AJPetz6NMejDK5HQ55rU8RW6654akaAZubY+Yh7hlrIBwQK1dEuxbXgyf3cvyn0z2NJuzUl0OPG0uaF10MDR7sXttFJjDYwR6HvWvC/OM7WzWPfWx0XxPPbni2vP30JxwD3FaaMePzBrCvBJ6bM4acuaJuWUxJJBwe6V0/wZkOfE0I6Lf7vplBXGW0gZsdDXVfBwlfEXiqJiOXhk/Ncf0rbLf4kl5fqeHncf3cX5/oYXxgXZr0D+qf1qa0kI8f+EpsfLNp80f1wAaf8bY9t/ZPgfxCs25uBb6t4DvCcL+9i/NP/AK1etUV4W8mfO0n+8+aPQPEd7vZbdDwOWrJXIA7moGmaad3b+I5q/YQNcTxRoCdzV50Nj1paHTeErAKpupOp4WtfULtYopJHIVVB+Y9AB1NTbBaWiRJwcY/xrhfGuqG4ZdLtsnzMeew/gT0+pq6kuWNjOjTdWdkc5Ndm5ubvVZv+Wnywj+7GOn59a425uXuJGeTqTn8PStvxDfAbLWHhU+8B2HpXOk5Y1xR1959T7nLsOoRuKTjGOtTQKd2etQJgmrsK4xirPRkyzGNoHFO0W0fUL6aQcqzBAfRR/wDXqO8nFvaOxzu6KPc9K6zwdpxhtEBAyQOfU96xxM+SFl1PCzSslFR+Z1fh6xSHaMZxXSp14FUrCJYIx/ePXFXkPoaijHljqfIVp88rkq8EDPFSoATUCsGbg1aiGRx1rpirmDLcCjjFXYVHFVbcdPSr8IBPpXdSRzzZbgTpzV5BgVBCMCrK9K9KjE45sUUUUV2mYUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFBoopMBrDIqrOvUVbNQTDiuaoi4syZxjNUZhkVpXK/NVGUZPpXDUidEGZsyc5FQOgP+NXpVwapyelcM1Y6Ysrnrgmo2T5akk4I45qOQfJkc1zyNUQcE4P4V5P8U9KNnfx6rbphVID16sAc5J5rK8UWMepadJDMm9ccjtWTfLqdmErOjVUkeRq4mhEgwQwzVWRe4HNM04G3u7ixfOYmIXPp2q1KuAa6L3PvKNRTipLqU3AHPelzuTbkg+vpQ/LEDNRildo3spKxq6xanXtCWaLA1GyO5R3bHUfjWXZXIubSOVO/Ve4PcVd0y9axu0lOPKb5ZB7etVtWszpOvM0X/HlfHeh7K/cfjSlG8eXtseLVh7Gpboy7bybXw33SOoNdT8IpCnjfX493yyWsLj8CRXJRgEdME10XwpkEfxHu0OP3unjj6PVYHSt8jys6jfD37NF744R/LZtnncR+lcf4hLf2D4LuFHEd7sJz6giu6+NqKbK1bByJP6VwOvbj4C0SRf8AlhqUZJ+px/WvYe1vU+Tj8f3HaRNnBHSuy8G2oy9y/ReBXD2u5nVR3PFejWTLY6bGgABxk15UJKKuz2aib0Q7xVq8emafPcvyVGFX1PYV5XfXjafZPcXDbru4O9vdj2rV1/Uv7Y1cknNjYkjPZ5PX6CuF1C/a/vZJsHykO2P39TWM5OpLyPayvB7eZCzsxZpDl3O5j70xcFuabnmhRuOM0mz6uEVFWRYhXPar9upC9OKrW8fHvVt2EMDyP0UZxTRnUnZDbeM32swwY3JF87fXtXqWj22dioMAVxXgXTnMJupkxLKdx/pXptpCLeMAD5sZNclR+0qeSPi8wxPPNtFpCOnp61ImBggVCvK596mjGTxmt0eOyVFO7IOBV+EYzVaCPGBirkQw3tXRTRlJl2AYwRV+BRxmqcG3IGc1pWygjNejSic02XIR8oqcVHGMKKkFenSRySYUUUVsSFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAGopBkVKaaRxWU0NGdOgPQ8Cs+ROPWteUAfWqE8Z5xXHUibQZlzLzxVKVMNmtGb5R05qnNg9q4KiOmLKbqcZJ/GoHPynnnpVls/hVWZh0OK45I3TICOTTXAZCG6EYNKTwaXKnpWVjS5418SdPOm6nHfwqQmdshHHB6Gs5SJY0kA4IzXqfjbS49U0aZHGcKa8e0OVvKlt5uJYWKkVdLRW7H1mT4rnhyPdFhx+dQGrkmAeKrP0NW0fQRYgw6lW5BGDWlbL/AGxos+lzNi5g+aFu/H3TWXg4pRO9ndxXked0R+YA/eXuKGm9DmxdH2kNNx2mTtLCRKcXER2SL6MK6T4ePs+JVmQAPMsZVP4EGsTxJHFbXFvrdsc2tzhJ8dAezVpeD5DH8SNAcjiSOZMjoflzTw0bV0+9z5vM5c2Fknurfmdl8ZY9+iI/pIK811Yg/C52BJMF5E/r/GK9U+L0XmeHHJ6KwNeWXeH+Fmtj/nkyuPwINewui8z5HZt+R1+jSLJqNvGMlzg4Haug8X6k9tZCC1Obmc+XH7erfgK5fwI4ubwXDAf6oNn2xUt9erNfXepTEfZrcGKE+uPvH8+K8Sd07I+kw9P2k0YviG4WztIdMtmbe6/O3cDufxrB4UKqn5QMCleV7q5lu5s+ZKcKP7q9hTAck8fShR5VY+ywlH2cNdxQACCaliU5DCo14q5bjOMg0WOmTsWIF4NV7oNe38NhFkjIeQ+g9KtyutvbtI+NqDNaXgnTS4a/nU+bP83PYdqmrL2cHI8fMcQoQ5VuzvfDVqqRKQPlQAY966AAlhk1m6QRHb7Tgc1phwSMHg+1ctLSJ8dXbcmOC7R6ip41zgk9KiXBPNWI1JwBxXRE52WYRkjHWrsQJIxx61VhjIOc8VowR8Cu2lC5hNlm1jJbIFa1vHgCqtomME1ooMCvSpwscdSQ8UtIKWvQirIwCiiiqAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigApDS0UmrgV5U6mqcyHnvWkRVaZMiuWcTSLMaZM54qnMgAPrWrNGRkHpVKaMHpXBUidEWZDnBIxVGYDeTWrKuG6c1SnjB+tcM0dMWUjyDigD17UpXHHak69QKwZqiOUBgQRweorxDxLZrpfjWQJkRXH869yb6814/8VlxrNpMg5DgHHrTi7NHp5XNwrqxmyrnPA+tVnU81oMmQD61WkXjNa2PtospY9M0owxOelSkcn0qLGCc1L0NNzS8OGK5hu9EvMtE65jz/dP+FUfDDTab470CxuGy9veGNCf4kZDimq7W88N3EMvEcn3XvWjrkMa+LPCmqRkYa+jQt6g1pRdqq8/zPmc5o8tObXY9N+KUZk8MXAxkgZ/WvJ7INL8P/E0PcQMfpxXsvxDXd4avBz9w1494XVpvD3iKEYJa1fH/AHya9X/M+Je/yNHwvd/Y/AjXseGnmijii9dxAFVNexDbWumRH5I0DTe564/E1X8FOLnw9oMUjYjiXz3AHXavH61HdzGWaWYg5kYt+HavKqrlb9T7bJqPtLTZTkPbpTQMGlb73vTgpKgVhc+r2Q6MZYd6vwJjnFQ20WRk1fjQVSMZsoanGbu6stPTlriQbgP7o616LZxiJVijGAoCjHtXC6TGT41tyy5At2K+xzXoVin+kYH51yY2V5KJ8rjpuVaXkbNjAcDPStJF4x0FNt4wkSg5JH61KMEgU6cbI8GcuZk0WOnU1ciQYBIPNV4o+QTWhbpkda6oGEixCgzwOMVegUE9KghXOB2rSt4+mPrXoUYnNNlqBRwAatgcVFCo28VOK9OnE5JPUBRRRXSQFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFACGopBkcVMaaRWU4jTM6ZO1UpUwcetas429KoTD5ulcVSJtBmPcR4J4qm/Q1rTrms2aMDtzXn1Y6nXBmdNwSKgcZI55FXJVAHTmqrrnNckkbxYwnt6V5J8Rm8/U7SFed0pYn2FeszP5cbEkDA4zXjmqXH9oeIrmQnKQHYuPXvWduaaPWyinz1r9hpxjB61XkXjpxVwqTjPSmSLknPrXW0fXplBkwOeKhIJzVyRDkYPTtULr+NQ0bKRABwMjjpii/vNukaQH+/b6nCq59A3+BpxO3tXO6lO0hnjOWWGaOcD0O4VpRXvp9meVnMb4eXoz6U8ZR+b4du1GOYj/KvGPAS7xq0Q6vbMP0Ne163++8Pyc53Q5/SvFvh4QusXSE8mNhivSfws/PPtI5/wACz+XoMe9sFYWj2/8AAsVfnPPBrmNFkC2ckbErsnliz6fMTXSkhkU9RivNxCtUfqz77IGnh0/QjAyeamhTjrxTQNxznpVmNc8dBXOke9KVkTW6YGR+FWuRnHNMgX2xUjDI9MVcUYSdys032LUrK/PCxvsf/dbivRNMBLbgc55Brz6eBZ4njflWGK63wpfF9NhEn+tT9234cVx42G0zwc0pWlzrqd7GeE56ip0GCM4qnYgGMOT1q9EpJGO9On7yPmJ6MswjLcVoQjBGOtVLdeemK0oFBwT2rupROebLNslacEXy85qnarzx0NasK8V6lGByVJEiKFHAp4pBS16EFY52FFFFWIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACkNLRSauBDMuV96qTLgdqvuu4VVmiABrnqRLizHnByaz5x1z1rXuI896zpowSeK8+rE6oSMqUdccVTcFTWlOnJ55qhMpHJ5rgnE6os5jxvqP9n6HO4++wwo9T2rzjSrYpbDfku/zsfet34mXD3Or2Gnp93d5jj2FVoIiBUUY3bkfU5VD2dLm6shEfGSKrzL68VpPEdvPWs+4XDGuho9iErlYrk5qCVNvParRHTH61GygjBxkVm0bJmVqDGO3JHU1y8SPJpmt3JJJ3AD6Ljiun1xdsK8nGawdIQSeGNSBPXzevrVX5IJ+aPLzB+0vHyf5H0qrfaPC0Lj+O2U/mteL+Bzs8VODnPzivXfC8hufA+lOed1nGf/HRXkHhseR45ZT0MrgV6TXus+BfxI4eSFjb6yqfehv5T6Y+auk0uQz2EL45K4P1rOu126p4thxgLeOw49QDVzw6M6Rb/SuHFL3n6n2nDs37Pl8i+iYJq9CuSOKrxrk9etW4cBu5rmSufRSZKgwTgVKR0PFMB/KpRGHA5z+NaJGMpWIhz0qfRZXh1UxH7koDr9R1pTD8h9apSloLq3lH8L4P0NZV6fPBo4sX79No9a0mYOhX8q2bcZrk/Dc6uEJ+9jBFdZafMw5/CuTCq6sfH4hcsmjRhQAj1rQhHHSqUKgtgda0rSLkZr16MDgqMu2akrkjArSjGFFQQJwPSrAHFenTjY45O48UUUV1ozCiiimAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFACNkjg4qJlZuDU1BqJRuBmTpWZOCpPFblwmRWXcJ15rhqxOinIxrhDnOOaz7pQoZieAK1p16kDmsrVRts5Txnaa86qrXZ2U9dDxu+c6h4yv5uCkQCLzmtOOI45xk1neH4vMu9Qmxy05H4VuMmBnOKmkvdR9jSfJBRRRuRtTB61kXD8kcE1o39zGhKu6g/Wsd3VzlTn3q5HdQdwBz1zSEEkECkJzjJpQ2ODWZ0mZr4zZk9x3rA8KfvND1CMg8PID+VdLq0bSWUgXqRmuV8JyGG+v7Fx/rVMi/wAiKKivRduh5uLX7xeaZ7/8NJDP8NtEc9fsoB/DivKof3XxAK/9PBr0j4PTGT4a6ZkH5BJGc+zGvONVf7P8QWxx/pA/WvVezPgXo0c/rQ8rxT4vQjBLqw/FKv6JF9n062iIzhRzVPxg2z4gazboPmuUgx+XJrcSMIqqOcDFefin733fkfZcOw/cuXyHKKnTgDgY71EOBjrUgztArmSPoWyZW5zzU0PJzmqgYBeSAKmiuYkA3OMDqa0RzVJWNBTkVT1SIvZybfvAZH4c1ct3SZQUIK+oqaWIPGy4PIIp2OaTNjwXIZIIXbqcGvRLRQGBzya818DOVgjVuqsF/CvTrRSSCw71xYWNpNHymO+I1bVB6c1qWwxVG2XLggVqQJ8ox1r3KMDx6kizESO1T/hUargDipM+1d0FY5mOHTmikBpa2QgooopgFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUGiikBDMuQazriPnNazDNUrhBg+tc9SJcGYkyHBrA8R5XTZsenaunnjyOawPEMebCUYJGK8vEx91nfQfvI8j8LR/6PcA/eMrGoPHWoSaVockkJxIx2g+lbXhqHbBcLjH7w03xZpg1DRrmDYGcodmf72OKVJaI+pc3sj50ul1O4uWuru/nVmYEbXzhT7V0Wm6pdac6Q3sm9T92Xsw9/Sqlz+8gUMACBtbjoR2qTTpVngNlcAFx9wnv7VU6ja1WiKpUvZtODd35nYWmpxXG0EjNaBYEDB49a87+xXFvIWspdoH/ACzfp+FXrfX5rRgt3G8f1GV/Os+VS+FnoQxfLpVVjtHw6lS3HSuC115NK1q3uYwcK2Gx3U9a3YfEVuyZ3Ln/AHqwvEF6moyiOEB3fgBeacINXUticXOFSF4vU9w+B0wl8BKEO4JczKPYbs1w/i5TD49Yn/nqhGa639n4GHwdeWzH5oL2RSPTgGuY+IoCeNN3rtP613rXY+Bqqzt5mV4st0PxRMjcE2KOB6nJFXwO9ZnxKaSDxvp08QJ3WBLEc8Bu9Ul8SRKnzAbvrXFXpuUk12R9hkeJpww3LLo2dETmq91fRW6nc4BFc5Pr09wxS3RiSeiDJqKHS7y6fzLtzHH/AHe5rBqMNZs9OeM5tKauWJNVkvJSlsNxzx6fjU8ek3V1GWnunyBkonCgCrtjYRxKFgXHrgVBruom1heztyN8q4lbP3V9Kw9s6k+WGiOSpzWvJ3bIfAs1w/im5tYmdrMxb9rHO3mvTmhKxMeD8tcf8KNMLi71OWMgSERxE91HWvRLiMCCQjBAU/yrttcxU+VWKXgxMqmem7pXqdkPmGM4rz3wZblYotw5Jr0vT4yce1ceFjebPnsdLU0rVOQccVpwr6VVtk56VoRLha9ylE8abHqKdRRXYlYyCiiiqAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAA1XnBPQVYprdDWU0NMyLheuRzWNqiH7JJgA5GOa6GdMtx0rMvotyMD0PFcNaF0dVKVmeSaEpS8v4DxtkyK0riLK4xwKinhNn4slXos6Z/EVcl+63HFctHWB9NCfNZ9zxbx74eOn3cl9aRM1nKczqvPln+8K4q7tWBV42H95HXvX0DqluJI2VgCCOQR1ryPxJZpoV6cqDpkz4K94WPce1U9Xpud0Wra7GZp9+l03k3eIbkcAno1XprYgYkXK+p5zUF9owmjWSL95GRkFetU4L2909hEym5g/uv94VyyhfWH3HVrHfVFh9MtpW/1KHueOtXrK0gtWDRRIp9hUVrqNjcttMhtpO6uMVppbbxmOSNgeQVNYTlJaSBKG6R3nwNkBh8QxDjbehvzQVgfFhNniqJgMZQfzrV+BxaPWPE9uwwweGT81I/pVT4yR7NatZAOShB/OvZo/CvRHxGMVqs15v8yj4kdIvGnhmZgCs1pLE27oeAcVYvdL0otv8Astvu/wB3rXP/ABPkcQeELmMkSBmXP/AKhtdX3qouZViYdSa8vHU5txlHt+rPbylRlCSl3/RGs8cMTEQxomOm1arlSzHoR3PYVVl1K3zi333Un+yMLT7TRdX16VVwY4CfuIMD8a4oUZN6nucyitCvLqWHMOm/PIesmOB9KoW+kS6pqiWEZLyZ3XEg6Ivp9TXUeKtGHhTRrdLfaNRvJBDF/s56t+FdF4P0iDTLJI4vnkPMkh6u3c16UMP7Jbas53VVT4Tc0ewjsrSK3gAWNAAABVrU8R2E2OMrgfU1atosY9MUzU4vMEEC/wAcgJ+grR2jG5y1Zl/wzbAJEpH3QBXf6fFnGBiuc8P2pEq9OK7azhKoOKWApaXZ83jKl5E0MWME1ZFIowKdXtQhY81u4UUUVqIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoPSiik0BBMny8VmXKdsda2WGRVK5j/ACrlqRNYSPM/Gdv9n1C0vMfdfafoaZIAy54wa6LxfYi802VcfMoyPrXK6bKZ7JC3LL8reuRXBFcsnE+hwdTnpryM3W5EtbWWd/uopJrw7xxqMusXn2O1UeVGwaVx90H0r37UbaO5gkimUMjjawryG40pdGuHsdQTZBJKzQ3IHDZP3W96JPlV0j06b5nyt6GXpV2iRLHIR8owDV+S2t7wBlUA96gu9BK7jDh165Q1nfZby1YtG7Y6YNczTR6sWrFubRIpYyHiJz3IzVP+wJrfJtriWMdhnIq1DrF5b4DxsVq9B4ht3+WeL68U9Gv6YnFN7G98DRNb+L9ft7mQySPbxSbj6ZIq/wDGuPbc2MmRyGFVPhjeQT/Eq5NvgCXThkfR/wD69a3xrjBhsmP948/hXo09ErHw+YK1aa8zgfiZH5/hLwrIpIP2gID9VNWvCnw/OoRpdXLEx5/i6VH4ycf8K50a44zBeRn9SKj0/wAaXNlEYlkJi9OmKyqJNLm21PQyxytJLy/I9JtPDui6YA1wVYr0QdKff+J7Wwj8uxiReMDArzxtflvAGTe+etMistS1FsRxSbSf4RWDxEYaUo2PcWGi/eqyv+RU+IF5Nr0UZWQm5gfzIwP5V2vwz1CfUtDjluVYSKSpJHXFc3qujz6PHa24h36hdkrFF392PsK73wdo40fSobYsXcfM59SeTSjKcl7xnUUE7wOii4AwKfbxGbUw2CVjHH1NPjACk+laGg2zOwc9XbJpV/hUV1POxNS0TrdBtAsQYrgmuhRcDFVrGERwquOgq2K9LDU+WKR8zVnzSbFooorsRiFFFFMAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigANMkXcOlPoqZRuBjXlr5iOuOtefXNhLp2ryxgHyZvmXjvXrWB6CoZbS3mIMtvC5HTcgOK5p4Xmd0zsw2LdF7XR5TNC3YfpXnnxMnkgsGtYrfzZZ1xyM49D9a+lzY2h62sH/fsVDNo+mTlTPp1lIR0LwKcfmKPqut7ncs2SVuU+PNHg1KytIlmDu4HOea143MoAmh+b3Wvqk6FpB66XYH/ALd0/wAKQ6Do566VYf8AgMn+FYPAy6SO2PEEUrcn4nzJDpkEoBMRJP8AdpzeFbebJ2kMfVa+ml0LSF+7pdgPpbp/hUg0jTR00+zH/bFf8Kf1G61aE+IF0i/vPmfwZoZ0f4nWOwZWexlU8ehBroPjJZPLpVs6KSVkr3YaNpguUuBptkJ0BVZBAu5QeoBxkU+60vT7tNl1Y2syddskKsP1FdFPD8iSvseLicV7ecp23PkbxVYs/wAJMFWzHcRnH/Ax/jVWw8KxyTwrO5VCQCfavryXw9ostqbaXSNOe2PJia2QofwxigeHtFGMaRp3H/Tsn+FKWG5lYvDY32F/M8VsfD2g6ZGnlx+aVHfvSX+uLaxldPtgo6Aha9w/sfTMY/s6zx/1wX/Ck/sXS/8AoG2X/fhP8Kh4aS+Cy+R3RzaH24t/M+WpJdQufG2m3M8bN5gaIFh0zzmvUbW1kVAGXJ+leqf2Lpe9X/s2y3pyreQmR9OKn+xWv/PtB/37FTHBtayY55zF/DCx5a1rKyiNAcscfhXXeHtOIKsR8q10os7YHIt4Qf8AcFTKiqMKoA9hT+pXmpNnDXxzqqyQiLgYp1FFdkYqJ59woooqgCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The cryoprobe is first placed at the fundus, angled toward 1 cornu. Probe placement is visualized on ultrasound. When the freeze is initiated, the progress of the iceball is monitored by ultrasound.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Levy, BS. Her Option Cryoablation Therapy System: Using Ultrasound Guidance. OBG Management 2005. Copyright &copy; 2005 Dowden Health Media.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Endometrial cryoablation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 373px; height: 274px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Probe placement on the left side of uterus with ice ball formation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_63_9204=[""].join("\n");
var outline_f8_63_9204=null;
var title_f8_63_9205="Levocetirizine: Pediatric drug information";
var content_f8_63_9205=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Levocetirizine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?43/45/44757?source=see_link\">",
"    see \"Levocetirizine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?13/7/13428?source=see_link\">",
"    see \"Levocetirizine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F5183881\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Xyzal&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F5599258\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antihistamine",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F5599269\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?43/45/44757?source=see_link\">",
"      see \"Levocetirizine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children 6 months to 5 years: 1.25 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children 6-11 years: 2.5 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children &ge;12 years and Adults: 5 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     <b>",
"      Dosage adjustments in renal impairment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children 6 months to 11 years: Avoid use",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children &ge;12 years and Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     50-80 mL/minute: 2.5 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     30-50 mL/minute: 2.5 mg once every other day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-30 mL/minute: 2.5 mg twice weekly",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute or on hemodialysis: Contraindicated",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosing adjustment in hepatic impairment:",
"     </b>",
"     No dosage adjustment necessary.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F5027664\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, oral, as dihydrochloride: 0.5 mg/mL (150 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Xyzal&reg;: 0.5 mg/mL (150 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as dihydrochloride: 5 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Xyzal&reg;: 5 mg [scored]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F5183882\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F5599270\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer without regard to food in the evening.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F5599266\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at room temperature.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F5599259\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Relief of symptoms associated with perennial allergic rhinitis (FDA approved in ages &ge;6 months and adults), seasonal allergic rhinitis (FDA approved in ages &ge;2 years and adults), and treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria (FDA approved in ages &ge;6 months and adults)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F5183880\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Levocetirizine may be confused with cetirizine",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F5184416\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Central nervous system: Fatigue, fever, somnolence",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gastrointestinal: Constipation, diarrhea, vomiting, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular &amp; skeletal: Weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Otic: Otitis media",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Respiratory: Cough, epistaxis, nasopharyngitis, pharyngitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rare but important or life-threatening: Aggression, agitation, anaphylaxis, angioedema, bilirubin increased, blurred vision, dizziness, dyspnea, dysuria, fixed-drug eruption, hepatitis, hypersensitivity, myalgia, nausea, palpitation, paresthesia, pruritus, rash, seizure, suicidal ideation, syncope, transaminases increased, urinary retention, urticaria, visual disturbances, weight gain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     The following potentially-severe adverse reactions have been reported with cetirizine and, therefore, may also occur with levocetirizine: Cholestasis, glomerulonephritis, hallucination, hypotension (severe), orofacial dyskinesia, suicidal ideation",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F5599261\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to levocetirizine, cetirizine, hydroxyzine, or any component; end stage renal disease (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute); patients undergoing dialysis; children 6 months to 11 years with impaired renal function",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F5599415\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with mild to moderate renal dysfunction and adjust dosage.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F5599262\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Safety and efficacy for the use of cough and cold products in children &lt;2 years of age is limited. Serious adverse effects including death have been reported. The FDA notes that there are no approved OTC uses for these products in children &lt;2 years of age. Healthcare providers are reminded to ask caregivers about the use of OTC cough and cold products in order to avoid exposure to multiple medications containing the same ingredient. May cause drowsiness; avoid concurrent use with alcohol.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299591\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F5184421\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): Anticholinergics may diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May diminish the sedative effect of Antihistamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzylpenicilloyl Polylysine: Antihistamines may diminish the diagnostic effect of Benzylpenicilloyl Polylysine.  Management: Suspend systemic H1 antagonists for benzylpenicilloyl-polylysine skin testing and delay testing until systemic antihistaminic effects have dissipated. A histamine skin test may be used to assess persistent antihistaminic effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Betahistine: Antihistamines may diminish the therapeutic effect of Betahistine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Antihistamines may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving antihistamines (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F5183886\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F5183887\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have not been observed in animal reproduction studies; therefore, the manufacturer classifies levocetirizine as pregnancy category B. The use of antihistamines for the treatment of rhinitis during pregnancy is generally considered to be safe at recommended doses. Information related to the use of levocitirizine during pregnancy is limited; therefore, other agents are preferred. Levocetirizine is the active enantiomer of cetirizine; refer to the Cetirizine monograph for additional information.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F5599267\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Levocitirizine is the R-enantiomer of cetirizine, a metabolite of hydroxyzine. It competes with histamine for H",
"     <sub>",
"      1",
"     </sub>",
"     -receptor sites on effector cells in the GI tract, blood vessels, and respiratory tract.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F5599416\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Duration: 24 hours",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F5599268\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: Well absorbed from the GI tract",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     :",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children: 0.4 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Adults: 0.4 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protein binding: 91% to 92%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: Limited hepatic metabolism (~14% of a dose); metabolic pathways include aromatic oxidation, N- and O-dealkylation, and taurine conjugation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children 1-2 years: ~4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children 6-11 years: ~6 hours (24% less than adult half-life)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Adults: 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Time to peak serum concentration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children: 1.2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Adults: Oral solution: 0.5 hours; Tablet: 0.9 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Elimination: 85.4% excreted unchanged in urine; 12.9% in feces",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Clearance:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Children 1-2 years: 1 mL/kg/minute",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Children 6-11 years: 0.82 mL/kg/minute",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Adults: 0.63 mL/kg/minute",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dialysis: &lt;10% removed during hemodialysis",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F5599272\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?13/7/13428?source=see_link\">",
"      see \"Levocetirizine: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May cause drowsiness and impair ability to perform activities requiring mental alertness or physical coordination; do not exceed daily dosage; may cause dry mouth. Although not reported with levocetirizine, cetirizine may cause photosensitivity reactions and avoiding exposure to sunlight may be appropriate.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Cranswick N, Turz&iacute;kova J, Fuchs M, et al, \"Levocetirizine in 1-2 Year Old Children: Pharmacokinetic and Pharmacodynamic Profile,\"",
"      <i>",
"       Int J Clin Pharmacol Ther",
"      </i>",
"      , 2005, 43(4):172-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/63/9205/abstract-text/15966463/pubmed\" id=\"15966463\" target=\"_blank\">",
"        15966463",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Simons FE and Simons KJ, \"Levocetirizine: Pharmacokinetics and Pharmacodynamics in Children Age 6 to 11 Years,\"",
"      <i>",
"       J Allergy Clin Immunol",
"      </i>",
"      , 2005, 116(2):355-61.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/63/9205/abstract-text/16083790/pubmed\" id=\"16083790\" target=\"_blank\">",
"        16083790",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13065 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-486B9E35E6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_63_9205=[""].join("\n");
var outline_f8_63_9205=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5183881\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5599258\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5599269\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5027664\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5183882\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5599270\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5599266\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5599259\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5183880\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5184416\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5599261\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5599415\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5599262\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299591\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5184421\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5183886\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5183887\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5599267\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5599416\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5599268\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5599272\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13065\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13065|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?43/45/44757?source=related_link\">",
"      Levocetirizine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?13/7/13428?source=related_link\">",
"      Levocetirizine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_63_9206="Clinical features of the carcinoid syndrome";
var content_f8_63_9206=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features of the carcinoid syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/63/9206/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/63/9206/contributors\">",
"     Stephen E Goldfinger, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/63/9206/contributors\">",
"     Jonathan R Strosberg, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/63/9206/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/63/9206/contributors\">",
"     Kenneth K Tanabe, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/63/9206/contributors\">",
"     David C Whitcomb, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/63/9206/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/63/9206/contributors\">",
"     Diane MF Savarese, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/63/9206/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 31, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carcinoid syndrome is the term applied to a constellation of symptoms mediated by various humoral factors elaborated by some carcinoid tumors (ie, well-differentiated gastroenteropancreatic neuroendocrine tumors that arise from the gastrointestinal tract and not the pancreas). These tumors synthesize, store, and release a variety of polypeptides, biogenic amines, and prostaglandins (",
"    <a class=\"graphic graphic_table graphicRef79329 \" href=\"UTD.htm?34/59/35771\">",
"     table 1",
"    </a>",
"    ). Some of these tumor products are responsible for the carcinoid syndrome, but the relative contributions of each and specificity of any for particular components of the syndrome are uncertain (",
"    <a class=\"graphic graphic_table graphicRef63079 \" href=\"UTD.htm?37/54/38763\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Carcinoid tumors may arise anywhere in the gastrointestinal tract, in the bronchi, and occasionally elsewhere (",
"    <a class=\"graphic graphic_table graphicRef56015 \" href=\"UTD.htm?17/7/17531\">",
"     table 3",
"    </a>",
"    ). The liver inactivates bioactive products secreted into the portal circulation. This may explain why patients with gastrointestinal carcinoid tumors only develop the carcinoid syndrome if they have hepatic metastases, resulting in the secretion of tumor products into the systemic circulation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/60/969?source=see_link\">",
"     \"Clinical characteristics of carcinoid tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The pathophysiology and clinical manifestations of the carcinoid syndrome will be reviewed here. The diagnosis and treatment of this disorder are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/8/11400?source=see_link\">",
"     \"Diagnosis of the carcinoid syndrome and tumor localization\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/61/39897?source=see_link\">",
"     \"Treatment and surveillance of non-metastatic carcinoid tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/32/6665?source=see_link\">",
"     \"Metastatic gastroenteropancreatic neuroendocrine tumors: Presentation, prognosis, imaging, and biochemical monitoring\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;As many as 40 secretory products have been identified in various carcinoid tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/1\">",
"     1",
"    </a>",
"    ]. The most prominent of these are serotonin, histamine, tachykinins, kallikrein and prostaglandins (",
"    <a class=\"graphic graphic_table graphicRef79329 \" href=\"UTD.htm?34/59/35771\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Tryptophan metabolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Altered metabolism of tryptophan occurs in almost all patients with the carcinoid syndrome. In normal subjects, approximately one percent of dietary tryptophan is converted to serotonin; however, this value may increase to 70 percent or more in patients with the carcinoid syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/2\">",
"     2",
"    </a>",
"    ]. Serotonin is then metabolized to 5-hydroxyindoleacetic acid (HIAA) (",
"    <a class=\"graphic graphic_figure graphicRef51368 \" href=\"UTD.htm?12/15/12542\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    However, some foregut carcinoids (gastric, bronchial (",
"    <a class=\"graphic graphic_figure graphicRef83185 \" href=\"UTD.htm?2/9/2198\">",
"     figure 2",
"    </a>",
"    )) lack the aromatic amino acid decarboxylase that converts 5-hydroxytryptophan to serotonin [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/3\">",
"     3",
"    </a>",
"    ]; these tumors produce 5-hydroxytryptophan (and histamine) instead of serotonin. Hindgut carcinoids (distal colon and rectum) rarely secrete serotonin or any other bioactive hormones and are therefore unassociated with hormonal syndromes even when metastatic (",
"    <a class=\"graphic graphic_table graphicRef56015 \" href=\"UTD.htm?17/7/17531\">",
"     table 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These alterations in tryptophan metabolism can explain many of the findings in the carcinoid syndrome.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diversion of tryptophan to the synthesis of serotonin in patients with widely metastatic tumors may result in tryptophan deficiency. This disorder may be characterized by decreased protein synthesis, hypoalbuminemia, and nicotinic acid deficiency with or without the clinical manifestations of pellagra (rough scaly skin, glossitis, angular stomatitis, and mental confusion) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Tumor production of serotonin is the most likely cause of the diarrhea in carcinoid syndrome. Serotonin stimulates intestinal secretion and motility and inhibits intestinal absorption [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/5,6\">",
"       5,6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Serotonin may also stimulate fibroblast growth and fibrogenesis. These effects can lead to the peritoneal and cardiac valvular fibrosis associated with the carcinoid syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/7\">",
"       7",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Cardiac valvular lesions'",
"      </a>",
"      below.)&nbsp;",
"     </li>",
"     <li>",
"      Serotonin does not cause flushing [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/8\">",
"       8",
"      </a>",
"      ]. Among the potential mediators are bradykinins, prostaglandins, tachykinins, substance P,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      histamine [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Histamine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary gastric carcinoids can produce histamine, which may be responsible for the atypical flushing and pruritus associated with these tumors. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Gastric carcinoid variant syndrome'",
"    </a>",
"    below.) The observation that flushing can be ameliorated by combined H1 and H2 antagonism is compatible with this hypothesis [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Kallikrein",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some carcinoids produce kallikrein, a protein that cleaves kinin from plasma kininogens. Bradykinin, a short-lived product of this cleavage, is a potent vasodilator and may be responsible for flushing in some carcinoid patients [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/10\">",
"     10",
"    </a>",
"    ]. Kinins also stimulate intestinal motility and increase vascular permeability [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Prostaglandins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prostaglandins E and F stimulate intestinal motility and fluid secretion in the normal gastrointestinal tract [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/12\">",
"     12",
"    </a>",
"    ]. Although elevated serum prostaglandin concentrations are found in patients with the carcinoid syndrome, their role in the symptomatology of this disorder is uncertain [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Tachykinins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some tumors secrete tachykinins (substance P, neurokinin A, neuropeptide K). Elevations in the serum concentrations of these latter polypeptides may contribute to flushing and diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/14-16\">",
"     14-16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seventy-five to eighty percent of patients with the carcinoid syndrome have small bowel carcinoids; however, the expression is variable in individual patients [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/3\">",
"     3",
"    </a>",
"    ]. Gastric and bronchial carcinoids are associated with atypical carcinoid syndromes. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Variant syndromes'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    As noted above, among patients with intestinal carcinoid tumors, the carcinoid syndrome rarely occurs in the absence of liver metastases. In contrast, bronchial and other extraintestinal carcinoids, whose bioactive products are not immediately cleared by the liver, can occasionally cause the syndrome in the absence of metastatic disease because of their direct access to the systemic circulation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Cutaneous flushing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Episodic flushing is the clinical hallmark of the carcinoid syndrome, and occurs in 85 percent of patients. The typical flush associated with midgut carcinoids (jejunum, ileum, cecum, appendix) begins suddenly and lasts from 30 seconds to as long as 30 minutes. It primarily involves the face, neck and upper chest, which become red to violaceous or purple, and is associated with a mild burning sensation (",
"    <a class=\"graphic graphic_picture graphicRef55493 \" href=\"UTD.htm?15/40/16000\">",
"     picture 1",
"    </a>",
"    ). Severe flushes are accompanied by a fall in blood pressure and rise in pulse rate. As the disease progresses, the episodes may last longer and the flushing may be more diffuse and cyanotic. The differential diagnosis of flushing is listed in the table (",
"    <a class=\"graphic graphic_table graphicRef78237 \" href=\"UTD.htm?36/53/37723\">",
"     table 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Most flushing episodes occur spontaneously, but they can be provoked by eating, drinking alcohol, defecation, emotional events, palpation of the liver, and anesthesia [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. Episodes induced by anesthesia may last hours and be accompanied by severe hypotension (\"carcinoid crisis\"). This problem can be minimized by pretreatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/61/39897?source=see_link\">",
"     \"Treatment and surveillance of non-metastatic carcinoid tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Venous telangiectasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;These purplish vascular lesions, similar to those seen in acne rosacea, appear late in the course of the carcinoid syndrome. They are due to prolonged vasodilatation, and most often occur on the nose, upper lip, and malar areas.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Diarrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Secretory diarrhea occurs in 80 percent of patients and is often the most debilitating component of the syndrome. Stools may vary from few to more than 30 per day, are typically watery and nonbloody, and can be explosive and accompanied by abdominal cramping. The abdominal cramps may be a consequence of mesenteric fibrosis or intestinal blockage by the primary tumor. The diarrhea is usually unrelated to flushing episodes. Transit time through the intestine may be extremely short [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Bronchospasm",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ten to twenty percent of patients with the carcinoid syndrome have wheezing and dyspnea, often during flushing episodes. Carcinoid wheezing should not be mistaken for bronchial asthma because treatment with beta agonists can trigger intense, prolonged vasodilation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Cardiac valvular lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carcinoid heart disease is characterized by pathognomonic plaque-like deposits of fibrous tissue. These deposits occur most commonly on the endocardium of valvular cusps, the cardiac chambers, and occasionally on the intima of the pulmonary arteries or aorta (",
"    <a class=\"graphic graphic_figure graphicRef74687 \" href=\"UTD.htm?29/32/30211\">",
"     figure 3",
"    </a>",
"    ). The valves and endocardium of the right side of the heart are most often affected, because inactivation of humoral substances by the lung protects the left heart. The clinical manifestations and treatment of carcinoid heart disease are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12472?source=see_link\">",
"     \"Carcinoid heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Minor manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of minor manifestations associated with carcinoid tumors:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      As noted above, diversion of dietary tryptophan for synthesis of large amounts of serotonin can very rarely result in the development of pellagra [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/4\">",
"       4",
"      </a>",
"      ], manifested by rough scaly skin, glossitis, angular stomatitis, and mental confusion. Poor dietary intake and diarrhea or malabsorption can augment this process.",
"     </li>",
"     <li>",
"      Muscle wasting may occur as a result of poor protein synthesis.",
"     </li>",
"     <li>",
"      In addition to the mesenteric fibrosis associated with carcinoid tumors, extensive fibrosis can occur in the retroperitoneal area and other sites, causing ureteral obstruction or Peyronie's disease [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/22,23\">",
"       22,23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Persistent brawny edema of the face and to a lesser degree of the extremities may be an advanced manifestation of the syndrome in some patients with severe flushing attacks. This is particularly true for those with foregut carcinoids [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     VARIANT SYNDROMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients with functioning gastric or bronchial carcinoids have clinical and biochemical variations from the classic syndrome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Gastric carcinoid variant syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with the gastric carcinoid variant, the flushes may be patchy, sharply demarcated, serpiginous, and cherry red; they are also intensely pruritic. Diarrhea or cardiac lesions are unusual. The tumors that cause this variant syndrome secrete histamine [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Bronchial carcinoid variant syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with the bronchial carcinoid variant, the flushes can be very severe and prolonged, lasting hours to days [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/24\">",
"     24",
"    </a>",
"    ]. They may be associated with disorientation, anxiety, and tremor. Periorbital edema, lacrimation, salivation, hypotension, tachycardia, diarrhea, dyspnea, asthma, edema, and oliguria are other components of this variant. The specific hormone mediator of flushing in patients with bronchial carcinoids is unclear but it could be histamine. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/55/9082?source=see_link\">",
"     \"Bronchial carcinoid tumors: Epidemiology, risk factors, classification, histology, diagnosis, and staging\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Seventy-five to eighty percent of patients with the carcinoid syndrome have small bowel carcinoids; however, the manifestations and severity vary in individual patients [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/3\">",
"       3",
"      </a>",
"      ]. Gastric and bronchial carcinoids are sometimes associated with atypical carcinoid syndromes (see below).",
"     </li>",
"     <li>",
"      Among patients with intestinal carcinoid tumors, the carcinoid syndrome rarely occurs in the absence of liver metastases. In contrast, bronchial and other extraintestinal carcinoids, whose bioactive products are not immediately cleared by the liver, can occasionally cause the syndrome in the absence of metastatic disease because of their direct access to the systemic circulation [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9206/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Episodic flushing is the clinical hallmark of the carcinoid syndrome, and occurs in 85 percent of patients. The typical flush associated with midgut carcinoids (jejunum, ileum, cecum, appendix) begins suddenly and lasts 20 to 30 seconds. It primarily involves the face, neck and upper chest, which become red to violaceous or purple, and is associated with a mild burning sensation (",
"      <a class=\"graphic graphic_picture graphicRef55493 \" href=\"UTD.htm?15/40/16000\">",
"       picture 1",
"      </a>",
"      ). Severe flushes are accompanied by a fall in blood pressure and rise in pulse rate. As the disease progresses, the episodes may last longer and the flushing may be more diffuse and cyanotic. The differential diagnosis of flushing is listed in Table 4 (",
"      <a class=\"graphic graphic_table graphicRef78237 \" href=\"UTD.htm?36/53/37723\">",
"       table 4",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Diarrhea is a prominent complaint in the majority of patients with carcinoid syndrome and is due to rapid intestinal transit time. Right-sided valvular heart disease affects as many as 40 percent of patients. A minority may experience bronchospasm.",
"     </li>",
"     <li>",
"      Some patients with functioning gastric or bronchial carcinoids have clinical and biochemical variations from the classic syndrome.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/1\">",
"      Modlin IM, Kidd M, Latich I, et al. Current status of gastrointestinal carcinoids. Gastroenterology 2005; 128:1717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/2\">",
"      Kvols LK. Metastatic carcinoid tumors and the malignant carcinoid syndrome. Ann N Y Acad Sci 1994; 733:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/3\">",
"      Feldman JM. Carcinoid tumors and syndrome. Semin Oncol 1987; 14:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/4\">",
"      Swain CP, Tavill AS, Neale G. Studies of tryptophan and albumin metabolism in a patient with carcinoid syndrome, pellagra, and hypoproteinemia. Gastroenterology 1976; 71:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/5\">",
"      HENDRIX TR, ATKINSON M, CLIFTON JA, INGELFINGER FJ. The effect of 5-hydroxytryptamine on intestinal motor function in man. Am J Med 1957; 23:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/6\">",
"      von der Ohe MR, Camilleri M, Kvols LK, Thomforde GM. Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med 1993; 329:1073.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/7\">",
"      Lie JP. Carcinoid tumor, carcinoid syndrome, and carcinoid heart disease. Prim Cardiol 1982; 8:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/8\">",
"      Roberts LJ 2nd, Marney SR Jr, Oates JA. Blockade of the flush associated with metastatic gastric carcinoid by combined histamine H1 and H2 receptor antagonists. Evidence for an important role of H2 receptors in human vasculature. N Engl J Med 1979; 300:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/9\">",
"      Grahame-Smith DG. What is the cause of the carcinoid flush? Gut 1987; 28:1413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/10\">",
"      Oates JA, Pettinger WA, Doctor RB. Evidence for the release of bradykinin in carcinoid syndrome. J Clin Invest 1966; 45:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/11\">",
"      Oates JA. The carcinoid syndrome. N Engl J Med 1986; 315:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/12\">",
"      Metz SA, McRae JR, Robertson RP. Prostaglandins as mediators of paraneoplastic syndromes: review and up-date. Metabolism 1981; 30:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/13\">",
"      Sandler M, Karim SM, Williams ED. Prostaglandins in amine-peptide-secreting tumours. Lancet 1968; 2:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/14\">",
"      Vinik AI, McLeod MK, Fig LM, et al. Clinical features, diagnosis, and localization of carcinoid tumors and their management. Gastroenterol Clin North Am 1989; 18:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/15\">",
"      Makridis C, Theodorsson E, Akerstr&ouml;m G, et al. Increased intestinal non-substance P tachykinin concentrations in malignant midgut carcinoid disease. J Gastroenterol Hepatol 1999; 14:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/16\">",
"      Cunningham JL, Janson ET, Agarwal S, et al. Tachykinins in endocrine tumors and the carcinoid syndrome. Eur J Endocrinol 2008; 159:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/17\">",
"      Fink G, Krelbaum T, Yellin A, et al. Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest 2001; 119:1647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/18\">",
"      Maton PN. The carcinoid syndrome. JAMA 1988; 260:1602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/19\">",
"      T&ouml;rnebrandt K, Nobin A, Ericsson M, Thomson D. Circulation, respiration and serotonin levels in carcinoid patients during neurolept anaesthesia. Anaesthesia 1983; 38:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/20\">",
"      Marsh HM, Martin JK Jr, Kvols LK, et al. Carcinoid crisis during anesthesia: successful treatment with a somatostatin analogue. Anesthesiology 1987; 66:89.",
"     </a>",
"    </li>",
"    <li>",
"     Warner RRP. Carcinoid tumors. In: Gastroenterology, Berk JE (Ed), WB Saunders, Philadelphia 1985.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/22\">",
"      Morin LJ, Zuerner RT. Retroperitoneal fibrosis and carcinoid tumor. JAMA 1971; 216:1647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/23\">",
"      Bivens CH, Marecek RL, Feldman JM. Peyronie's disease--a presenting complaint of the carcinoid syndrome. N Engl J Med 1973; 289:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/24\">",
"      Melmon KL, Sjoerdsma A, Mason DT. Distinctive clinical and therapeutic aspects of the syndrome associated with bronchial carcinoid tumors. Am J Med 1965; 39:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/25\">",
"      Borch K, Ahr&eacute;n B, Ahlman H, et al. Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg 2005; 242:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9206/abstract/26\">",
"      Gough DB, Thompson GB, Crotty TB, et al. Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinemia. World J Surg 1994; 18:473.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2614 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-B3AA2FA6DE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_63_9206=[""].join("\n");
var outline_f8_63_9206=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Tryptophan metabolism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Histamine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Kallikrein",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Prostaglandins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Tachykinins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Cutaneous flushing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Venous telangiectasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Diarrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Bronchospasm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Cardiac valvular lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Minor manifestations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      VARIANT SYNDROMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Gastric carcinoid variant syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Bronchial carcinoid variant syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/2614\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2614|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/15/12542\" title=\"figure 1\">",
"      Tryptophan and serotonin metabolism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/9/2198\" title=\"figure 2\">",
"      Classification carcinoid tumors by embryonic derivation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/32/30211\" title=\"figure 3\">",
"      Plaques in carcinoid heart",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2614|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/40/16000\" title=\"picture 1\">",
"      Carcinoid flush",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2614|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?34/59/35771\" title=\"table 1\">",
"      Products of carcinoid tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/54/38763\" title=\"table 2\">",
"      Carcinoid symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/7/17531\" title=\"table 3\">",
"      Characteristics of carcinoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/53/37723\" title=\"table 4\">",
"      Causes of flushing",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/55/9082?source=related_link\">",
"      Bronchial carcinoid tumors: Epidemiology, risk factors, classification, histology, diagnosis, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12472?source=related_link\">",
"      Carcinoid heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/60/969?source=related_link\">",
"      Clinical characteristics of carcinoid tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/8/11400?source=related_link\">",
"      Diagnosis of the carcinoid syndrome and tumor localization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/32/6665?source=related_link\">",
"      Metastatic gastroenteropancreatic neuroendocrine tumors: Presentation, prognosis, imaging, and biochemical monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/61/39897?source=related_link\">",
"      Treatment and surveillance of non-metastatic carcinoid tumors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_63_9207="Microcystic adnexal carcinoma CEA stain";
var content_f8_63_9207=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85590&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85590&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Microcystic adnexal carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 381px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Microcystic adnexal carcinoma staining positively for carcinoembryonic antigen (CEA).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_63_9207=[""].join("\n");
var outline_f8_63_9207=null;
var title_f8_63_9208="Etiology and classification of stroke";
var content_f8_63_9208=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Etiology and classification of stroke",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/63/9208/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/63/9208/contributors\">",
"     Louis R Caplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/63/9208/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/63/9208/contributors\">",
"     Scott E Kasner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/63/9208/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/63/9208/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/63/9208/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two broad categories of stroke, hemorrhage and ischemia, are diametrically opposite conditions: hemorrhage is characterized by too much blood within the closed cranial cavity, while ischemia is characterized by too little blood to supply an adequate amount of oxygen and nutrients to a part of the brain [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Each of these categories can be divided into subtypes that have somewhat different causes, clinical pictures, clinical courses, outcomes, and treatment strategies. As an example, intracranial hemorrhage can be caused by intracerebral hemorrhage (ICH, also called parenchymal hemorrhage), which involves bleeding directly into brain tissue, and subarachnoid hemorrhage (SAH), which involves bleeding into the cerebrospinal fluid that surrounds the brain and spinal cord [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will review the classification of stroke. The clinical diagnosis of stroke subtypes and an overview of stroke evaluation are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/17/40216?source=see_link\">",
"     \"Clinical diagnosis of stroke subtypes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/47/28410?source=see_link\">",
"     \"Overview of the evaluation of stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stroke is classified into two major types:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Brain ischemia due to thrombosis, embolism, or systemic hypoperfusion",
"     </li>",
"     <li>",
"      Brain hemorrhage due to intracerebral hemorrhage or subarachnoid hemorrhage",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A stroke is the acute neurologic injury that occurs as a result of one of these pathologic processes. Approximately 80 percent of strokes are due to ischemic cerebral infarction and 20 percent to brain hemorrhage.",
"   </p>",
"   <p>",
"    An infarcted brain is pale initially. Within hours to days, the gray matter becomes congested with engorged, dilated blood vessels and minute petechial hemorrhages. When an embolus blocking a major vessel migrates, lyses, or disperses within minutes to days, recirculation into the infarcted area can cause a hemorrhagic infarction and may aggravate edema formation due to disruption of the blood-brain barrier.",
"   </p>",
"   <p>",
"    A primary intracerebral hemorrhage damages the brain directly at the site of the hemorrhage by compressing the surrounding tissue. Physicians must initially consider whether the patient with suspected cerebrovascular disease is experiencing symptoms and signs suggestive of ischemia or hemorrhage.",
"   </p>",
"   <p>",
"    The great majority of ischemic strokes are caused by a diminished supply of arterial blood, which carries sugar and oxygen to brain tissue. Another cause of stroke that is difficult to classify is stroke due to occlusion of veins that drain the brain of blood. Venous occlusion causes a back-up of fluid resulting in brain edema, and in addition it may cause both brain ischemia and hemorrhage into the brain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     BRAIN ISCHEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are three main subtypes of brain ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Thrombosis (see",
"      <a class=\"local\" href=\"#H4\">",
"       'Thrombosis'",
"      </a>",
"      below) generally refers to local in situ obstruction of an artery. The obstruction may be due to disease of the arterial wall, such as arteriosclerosis, dissection, or fibromuscular dysplasia; there may or may not be superimposed thrombosis.",
"     </li>",
"     <li>",
"      Embolism (see",
"      <a class=\"local\" href=\"#H7\">",
"       'Embolism'",
"      </a>",
"      below) refers to particles of debris originating elsewhere that block arterial access to a particular brain region [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/3\">",
"       3",
"      </a>",
"      ]. Since the process is not local (as with thrombosis), local therapy only temporarily solves the problem; further events may occur if the source of embolism is not identified and treated.",
"     </li>",
"     <li>",
"      Systemic hypoperfusion (see",
"      <a class=\"local\" href=\"#H11\">",
"       'Systemic hypoperfusion'",
"      </a>",
"      below) is a more general circulatory problem, manifesting itself in the brain and perhaps other organs.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Blood disorders (see",
"    <a class=\"local\" href=\"#H12\">",
"     'Blood disorders'",
"    </a>",
"    below) are an uncommon primary cause of stroke. However, increased blood coagulability can result in thrombus formation and subsequent cerebral embolism in the presence of an endothelial lesion located in the heart, aorta, or large arteries that supply the brain.",
"   </p>",
"   <p>",
"    Transient ischemic attack (TIA) is defined clinically by the temporary nature of the associated neurologic symptoms, which last less than 24 hours by the classic definition. The definition is changing with recognition that transient neurologic symptoms are frequently associated with permanent brain tissue injury. The definition of TIA is discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/21/18773?source=see_link\">",
"     \"Definition of transient ischemic attack\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Thrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thrombotic strokes are those in which the pathologic process giving rise to thrombus formation in an artery produces a stroke either by reduced blood flow distally (low flow) or by an embolic fragment that breaks off and travels to a more distant vessel (artery-to-artery embolism). Thrombotic strokes can be divided into either large or small vessel disease (",
"    <a class=\"graphic graphic_table graphicRef55099 \" href=\"UTD.htm?20/39/21117\">",
"     table 1",
"    </a>",
"    ). These two subtypes of thrombosis are worth distinguishing since the causes, outcomes, and treatments are different.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Large vessel disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Large vessels include both the extracranial (common and internal carotids, vertebral) and intracranial arterial system (Circle of Willis and proximal branches) (",
"    <a class=\"graphic graphic_figure graphicRef51410 \" href=\"UTD.htm?2/4/2122\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef65199 \" href=\"UTD.htm?41/34/42531\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Intrinsic lesions in large extracranial and intracranial arteries cause symptoms by reducing blood flow beyond obstructive lesions, and by serving as the source of intraarterial emboli. At times a combination of mechanisms is operant. Severe stenosis promotes the formation of thrombi which can break off and embolize, and the reduced blood flow caused by the vascular obstruction makes the circulation less competent at washing out and clearing these emboli.",
"   </p>",
"   <p>",
"    Pathologies affecting large extracranial vessels include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Atherosclerosis",
"     </li>",
"     <li>",
"      Dissection",
"     </li>",
"     <li>",
"      Takayasu arteritis",
"     </li>",
"     <li>",
"      Giant cell arteritis",
"     </li>",
"     <li>",
"      Fibromuscular dysplasia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pathologies affecting large intracranial vessels include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Atherosclerosis",
"     </li>",
"     <li>",
"      Dissection",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Arteritis/vasculitis",
"      </span>",
"     </li>",
"     <li>",
"      Noninflammatory vasculopathy",
"     </li>",
"     <li>",
"      Moyamoya syndrome",
"     </li>",
"     <li>",
"      Vasoconstriction",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Atherosclerosis is by far the most common cause of in situ local disease within the large extracranial and intracranial arteries that supply the brain. White platelet-fibrin and red erythrocyte-fibrin thrombi are often superimposed upon the atherosclerotic lesions, or they may develop without severe vascular disease in patients with hypercoagulable states. Vasoconstriction (eg, with migraine) is probably the next most common, followed in frequency by arterial dissection (a disorder much more common than previously recognized) and traumatic occlusion. Fibromuscular dysplasia is an uncommon arteriopathy, while arteritis is frequently mentioned in the differential diagnosis, but it is an extremely rare cause of thrombotic stroke.",
"   </p>",
"   <p>",
"    Aortic disease is really a form of proximal extracranial large vessel disease, but it is often considered together with cardioembolic sources because of anatomic proximity. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Aortic atherosclerosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Identification of the specific focal vascular lesion, including its nature, severity, and localization, is important for treatment since local therapy may be effective (eg, surgery, angioplasty, intraarterial thrombolysis). It should be possible clinically in most patients to determine whether the local vascular disease is within the anterior (carotid) or posterior (vertebrobasilar) circulation and whether the disorder affects large or penetrating arteries. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/17/40216?source=see_link&amp;anchor=H21#H21\">",
"     \"Clinical diagnosis of stroke subtypes\", section on 'Neurologic examination'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Delivery of adequate blood through a blocked or partially blocked artery depends upon many factors, including blood pressure, blood viscosity, and collateral flow. Local vascular lesions also may throw off emboli, which can cause transient symptoms. In patients with thrombosis, the neurologic symptoms often fluctuate, remit, or progress in a sputtering fashion (",
"    <a class=\"graphic graphic_figure graphicRef64107 \" href=\"UTD.htm?8/62/9197\">",
"     figure 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/17/40216?source=see_link&amp;anchor=H8#H8\">",
"     \"Clinical diagnosis of stroke subtypes\", section on 'Clinical course'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/46/40678?source=see_link&amp;anchor=H7#H7\">",
"     \"Etiology and clinical manifestations of transient ischemic attack\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Small vessel disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Small vessel disease affects the intracerebral arterial system, specifically penetrating arteries that arise from the distal vertebral artery, the basilar artery, the middle cerebral artery stem, and the arteries of the circle of Willis. These arteries thrombose due to:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lipohyalinosis (a lipid hyaline build-up distally secondary to hypertension) and fibrinoid degeneration",
"     </li>",
"     <li>",
"      Atheroma formation at their origin or in the parent large artery",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The most common cause of obstruction of the smaller arteries and arterioles that penetrate at right angles to supply the deeper structures within the brain (eg, basal ganglia, internal capsule, thalamus, pons) is lipohyalinosis, blockage of an artery by medial hypertrophy, and lipid admixed with fibrinoid material in the hypertrophied arterial wall. A stroke due to obstruction of these vessels is referred to as a lacunar stroke. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/59/4026?source=see_link\">",
"     \"Lacunar infarcts\"",
"    </a>",
"    .) Lipohyalinosis is most often related to hypertension, but aging may play a role.",
"   </p>",
"   <p>",
"    Microatheromas can also block these small penetrating arteries, as can plaques within the larger arteries that block or extend into the orifices of the branches (called atheromatous branch disease) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Penetrating artery occlusions usually cause symptoms that develop during a short period of time, hours or at most a few days (",
"    <a class=\"graphic graphic_figure graphicRef52246 \" href=\"UTD.htm?24/54/25453\">",
"     figure 4",
"    </a>",
"    ), compared with large artery-related brain ischemia, which can evolve over a longer period.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Embolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Embolic strokes are divided into four categories (",
"    <a class=\"graphic graphic_table graphicRef55099 \" href=\"UTD.htm?20/39/21117\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Those with a known source that is cardiac",
"     </li>",
"     <li>",
"      Those with a possible cardiac or aortic source based upon transthoracic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      transesophageal echocardiographic findings",
"     </li>",
"     <li>",
"      Those with an arterial source (artery to artery embolism)",
"     </li>",
"     <li>",
"      Those with a truly unknown source in which tests for embolic sources are negative",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The symptoms depend upon the region of brain rendered ischemic [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. The embolus suddenly blocks the recipient site so that the onset of symptoms is abrupt and usually maximal at the start (",
"    <a class=\"graphic graphic_figure graphicRef73261 \" href=\"UTD.htm?13/3/13373\">",
"     figure 5",
"    </a>",
"    ). Unlike thrombosis, multiple sites within different vascular territories may be affected when the source is the heart (eg, left atrial appendage or left ventricular thrombus) or aorta. Treatment will depend upon the source and composition of the embolus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/33/32281?source=see_link\">",
"     \"Secondary prevention for specific causes of ischemic stroke and transient ischemic attack\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cardioembolic strokes usually occur abruptly, although they occasionally present with stuttering, fluctuating symptoms. The symptoms may clear entirely since emboli can migrate and lyse, particularly those composed of thrombus. When this occurs, infarction generally also occurs but is silent; the area of infarction is smaller than the area of ischemia that gave rise to the symptoms. This process is often referred to as a TIA due to embolism, although it is more correctly termed an embolic infarction or stroke in which the symptoms clear within 24 hours.",
"   </p>",
"   <p>",
"    Cardioembolic strokes can be divided into those with a known source and those with a possible cardiac or ascending aortic source based upon transthoracic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    transesophageal echocardiographic findings [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     High-risk cardiac source",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of embolic strokes with a known cardiac source is generally agreed upon by physicians (",
"    <a class=\"graphic graphic_table graphicRef60843 \" href=\"UTD.htm?20/43/21181\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]; included in this category are those due to:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Atrial fibrillation and paroxysmal atrial fibrillation",
"     </li>",
"     <li>",
"      Rheumatic mitral or aortic valve disease",
"     </li>",
"     <li>",
"      Bioprosthetic and mechanical heart valves",
"     </li>",
"     <li>",
"      Atrial or ventricular thrombus",
"     </li>",
"     <li>",
"      Sick sinus syndrome",
"     </li>",
"     <li>",
"      Sustained atrial flutter",
"     </li>",
"     <li>",
"      Recent myocardial infarction (within one month)",
"     </li>",
"     <li>",
"      Chronic myocardial infarction together with ejection fraction &lt;28 percent",
"     </li>",
"     <li>",
"      Symptomatic congestive heart failure with ejection fraction &lt;30 percent",
"     </li>",
"     <li>",
"      Dilated cardiomyopathy",
"     </li>",
"     <li>",
"      Fibrous nonbacterial endocarditis as found in patients with systemic lupus (ie, Libman-Sacks endocarditis), antiphospholipid syndrome, and cancer (marantic endocarditis)",
"     </li>",
"     <li>",
"      Infective endocarditis",
"     </li>",
"     <li>",
"      Papillary fibroelastoma",
"     </li>",
"     <li>",
"      Left atrial myxoma",
"     </li>",
"     <li>",
"      Coronary artery bypass graft (CABG) surgery",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    With CABG, for example, the incidence of postoperative neurologic sequelae is approximately 2 to 6 percent, most of which is due to stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/8\">",
"     8",
"    </a>",
"    ]. Atheroemboli associated with ascending aortic atherosclerosis is probably the most common cause. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/47/3834?source=see_link\">",
"     \"Neurologic complications of cardiac surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Potential cardiac source",
"    </span>",
"    &nbsp;&mdash;&nbsp;Embolic strokes considered to have a potential cardiac source (",
"    <a class=\"graphic graphic_table graphicRef60843 \" href=\"UTD.htm?20/43/21181\">",
"     table 2",
"    </a>",
"    ) are ones in which a possible source is detected (usually) by echocardiographic methods [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/6,7\">",
"     6,7",
"    </a>",
"    ], including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Mitral annular calcification",
"     </li>",
"     <li>",
"      Patent foramen ovale",
"     </li>",
"     <li>",
"      Atrial septal aneurysm",
"     </li>",
"     <li>",
"      Atrial septal aneurysm with patent foramen ovale",
"     </li>",
"     <li>",
"      Left ventricular aneurysm without thrombus",
"     </li>",
"     <li>",
"      Isolated left atrial smoke on echocardiography (no mitral stenosis or atrial fibrillation)",
"     </li>",
"     <li>",
"      Complex atheroma in the ascending aorta or proximal arch (see",
"      <a class=\"local\" href=\"#H10\">",
"       'Aortic atherosclerosis'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In this group, the association of the cardiac or aortic lesion and the rate of embolism is often uncertain, since some of these lesions do not have a high frequency of embolism and are often incidental findings unrelated to the stroke event [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/9\">",
"     9",
"    </a>",
"    ]. Thus, they are considered potential sources of embolism. A truly unknown source represents embolic strokes in which no clinical evidence of heart disease is present (",
"    <a class=\"graphic graphic_table graphicRef55099 \" href=\"UTD.htm?20/39/21117\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Aortic atherosclerosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In longitudinal population studies with nonselected patients, complex aortic atherosclerosis does not appear to be associated with any increased primary ischemic stroke risk [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. However, most studies evaluating secondary stroke risk have found that complex aortic atherosclerosis is a risk factor for recurrent stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/13-16\">",
"     13-16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The range of findings is illustrated by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A prospective case-control study examined the frequency and thickness of atherosclerotic plaques in the ascending aorta and proximal arch in 250 patients admitted to the hospital with ischemic stroke and 250 consecutive controls, all over the age of 60 years [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/14\">",
"       14",
"      </a>",
"      ]. Atherosclerotic plaques &ge;4 mm in thickness were found in 14 percent of patients compared with 2 percent of controls, and the odds ratio for ischemic stroke among patients with such plaques was 9.1 after adjustment for atherosclerotic risk factors. In addition, aortic atherosclerotic plaques &ge;4 mm were much more common in patients with brain infarcts of unknown cause (relative risk 4.7).",
"     </li>",
"     <li>",
"      In contrast, a population-based study of 1135 subjects who had transesophageal echocardiography (TEE) found that complex atherosclerotic plaque (&gt;4 mm with or without mobile debris) in the ascending and transverse aortic arch was not a significant risk factor for cryptogenic ischemic stroke or TIA after adjusting for age, gender, and other clinical risk factors [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/11\">",
"       11",
"      </a>",
"      ]. However, there was an association between complex aortic plaque and noncryptogenic stroke. The investigators concluded that complex aortic arch debris is a marker for the presence of generalized atherosclerosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Methodologic differences are a potential explanation for the discrepant results of these reports assessing the risk of ischemic stroke related to aortic atherosclerosis, as the earlier case-control studies may have been skewed by selection and referral bias. However, many patients with aortic atherosclerosis also have cardiac or large artery lesions, a problem that may confound purely epidemiologic studies.",
"   </p>",
"   <p>",
"    In the author's opinion, there is no question that large protruding plaques in the ascending aorta and arch, particularly mobile plaques, are an important cause of stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Systemic hypoperfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reduced blood flow is more global in patients with systemic hypoperfusion and does not affect isolated regions. The reduced perfusion can be due to cardiac pump failure caused by cardiac arrest or arrhythmia, or to reduced cardiac output related to acute myocardial ischemia, pulmonary embolism, pericardial effusion, or bleeding. Hypoxemia may further reduce the amount of oxygen carried to the brain.",
"   </p>",
"   <p>",
"    Symptoms of brain dysfunction typically are diffuse and nonfocal in contrast to the other two categories of ischemia. Most affected patients have other evidence of circulatory compromise and hypotension such as pallor, sweating, tachycardia or severe bradycardia, and low blood pressure. The neurologic signs are typically bilateral, although they may be asymmetric when there is preexisting asymmetrical craniocerebral vascular occlusive disease.",
"   </p>",
"   <p>",
"    The most severe ischemia may occur in border zone (watershed) regions between the major cerebral supply arteries since these areas are most vulnerable to systemic hypoperfusion. The signs that may occur with borderzone infarction include cortical blindness, or at least bilateral visual loss; stupor; and weakness of the shoulders and thighs with sparing of the face, hands, and feet (a pattern likened to a \"man-in-a-barrel\").",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Blood disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood and coagulation disorders are an uncommon primary cause of stroke and TIA, but they should be considered in patients younger than age 45, patients with a history of clotting dysfunction, and in patients with a history of cryptogenic stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/9\">",
"     9",
"    </a>",
"    ]. The blood disorders associated with arterial cerebral infarction include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sickle cell anemia",
"     </li>",
"     <li>",
"      Polycythemia vera",
"     </li>",
"     <li>",
"      Essential thrombocytosis",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"       Heparin",
"      </a>",
"      induced thrombocytopenia",
"     </li>",
"     <li>",
"      Protein C or S deficiency, acquired or congenital",
"     </li>",
"     <li>",
"      Prothrombin gene mutation",
"     </li>",
"     <li>",
"      Factor V Leiden (resistance to activated protein C)",
"     </li>",
"     <li>",
"      Antithrombin III deficiency",
"     </li>",
"     <li>",
"      Antiphospholipid syndrome",
"     </li>",
"     <li>",
"      Hyperhomocysteinemia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Factor V Leiden mutation and prothrombin 20210 mutations are associated mostly with venous rather than arterial thrombosis. They can result in cerebral venous thrombosis or deep venous thrombosis with paradoxical emboli. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/26/7594?source=see_link\">",
"     \"Etiology, clinical features, and diagnosis of cerebral venous thrombosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Infectious and inflammatory disease such as pneumonia, urinary tract infections, Crohn's disease, ulcerative colitis,",
"    <span class=\"nowrap\">",
"     HIV/AIDS,",
"    </span>",
"    and cancers result in a rise in acute phase reactants such as fibrinogen, C-reactive protein, and coagulation factors VII and VIII. In the presence of an endothelial cardiac or vascular lesion, this increase can promote active thrombosis and embolism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     TOAST classification",
"    </span>",
"    &nbsp;&mdash;&nbsp;The TOAST classification scheme for ischemic stroke is widely used and has good interobserver agreement [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/18\">",
"     18",
"    </a>",
"    ]. The TOAST system (",
"    <a class=\"graphic graphic_table graphicRef62571 \" href=\"UTD.htm?3/28/3531\">",
"     table 3",
"    </a>",
"    ) attempts to classify ischemic strokes according to the major pathophysiologic mechanisms that are recognized as the cause of most ischemic strokes (",
"    <a class=\"graphic graphic_table graphicRef55099 \" href=\"UTD.htm?20/39/21117\">",
"     table 1",
"    </a>",
"    ). It assigns ischemic strokes to five subtypes based upon clinical features and the results of ancillary studies including brain imaging, neurovascular evaluations, cardiac tests, and laboratory evaluations for a prothrombotic state.",
"   </p>",
"   <p>",
"    The five TOAST subtypes of ischemic stroke are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Large artery atherosclerosis",
"     </li>",
"     <li>",
"      Cardioembolism",
"     </li>",
"     <li>",
"      Small vessel occlusion",
"     </li>",
"     <li>",
"      Stroke of other determined etiology",
"     </li>",
"     <li>",
"      Stroke of undetermined etiology",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The last subtype - stroke of undetermined etiology - involves cases where the cause of a stroke cannot be determined with any degree of confidence, and by definition includes those with two or more potential causes identified, those with a negative evaluation, and those with an incomplete evaluation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/10/40105?source=see_link\">",
"     \"Cryptogenic stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H60049534\">",
"    <span class=\"h2\">",
"     SSS-TOAST and CCS classification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since the original TOAST classification scheme was developed in the early 1990s, advances in stroke evaluation and diagnostic imaging have allowed more frequent identification of potential vascular and cardiac causes of stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/6\">",
"     6",
"    </a>",
"    ]. These advances could cause an increasing proportion of ischemic strokes to be classified as \"undetermined\" if the strict definition of this category (cases with two or more potential causes) is applied.",
"   </p>",
"   <p>",
"    As a result, an evidenced-based modification of the TOAST criteria called SSS-TOAST has been developed [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/6\">",
"     6",
"    </a>",
"    ]. The SSS-TOAST system divides each of the original TOAST subtypes into three subcategories as \"evident,\" \"probable,\" or \"possible\" based upon the weight of diagnostic evidence as determined by predefined clinical and imaging criteria (",
"    <a class=\"graphic graphic_table graphicRef57732 \" href=\"UTD.htm?38/58/39853\">",
"     table 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In a study that compared the original TOAST and the SSS-TOAST criteria applied to a series of 50 patients with acute ischemic stroke, patients classified as \"undetermined-unclassified\" decreased for TOAST and SSS-TOAST were 38 to 40 versus 4 percent, respectively, and inter-examiner reliability for SSS-TOAST was higher than for TOAST, although the difference was not statistically significant [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a further refinement, an automated version of the SSS-TOAST called the Causative Classification System (CCS) was devised to improve its usefulness and accuracy for stroke subtyping [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/19\">",
"     19",
"    </a>",
"    ]. The CCS is a computerized algorithm that consists of questionnaire-style classification scheme. The CCS appears to have good inter-rater reliability among multiple centers [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/20\">",
"     20",
"    </a>",
"    ]. It is available online at",
"    <a class=\"external\" href=\"https://ccs.mgh.harvard.edu/\">",
"     https://ccs.mgh.harvard.edu",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     BRAIN HEMORRHAGE",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two main subtypes of brain hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intracerebral hemorrhage refers to bleeding directly into the brain parenchyma",
"     </li>",
"     <li>",
"      Subarachnoid hemorrhage refers to bleeding into the cerebrospinal fluid within the subarachnoid space that surrounds the brain",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Intracerebral hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bleeding in intracerebral hemorrhage (ICH) is usually derived from arterioles or small arteries. The bleeding is directly into the brain, forming a localized hematoma that spreads along white matter pathways. Accumulation of blood occurs over minutes or hours; the hematoma gradually enlarges by adding blood at its periphery like a snowball rolling downhill. The hematoma continues to grow until the pressure surrounding it increases enough to limit its spread or until the hemorrhage decompresses itself by emptying into the ventricular system or into the cerebrospinal fluid (CSF) on the pial surface of the brain [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common causes of ICH are hypertension, trauma, bleeding diatheses, amyloid angiopathy, illicit drug use (mostly amphetamines and cocaine), and vascular malformations [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29130?source=see_link\">",
"     \"Spontaneous intracerebral hemorrhage: Pathogenesis, clinical features, and diagnosis\"",
"    </a>",
"    .) Less frequent causes include bleeding into tumors, aneurysmal rupture, and vasculitis.",
"   </p>",
"   <p>",
"    The earliest symptoms of ICH relate to dysfunction of the portion of the brain that contains the hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Bleeding into the right putamen and internal capsule region causes left limb motor",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      sensory signs",
"     </li>",
"     <li>",
"      Bleeding into the cerebellum causes difficulty walking",
"     </li>",
"     <li>",
"      Bleeding into the left temporal lobe presents as aphasia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The neurologic symptoms usually increase gradually over minutes or a few hours. In contrast to brain embolism and SAH, the neurologic symptoms related to ICH may not begin abruptly and are not maximal at onset (",
"    <a class=\"graphic graphic_figure graphicRef61491 \" href=\"UTD.htm?6/23/6526\">",
"     figure 6",
"    </a>",
"    ) (and see below).",
"   </p>",
"   <p>",
"    Headache, vomiting, and a decreased level of consciousness develop if the hematoma becomes large enough to increase intracranial pressure or cause shifts in intracranial contents (",
"    <a class=\"graphic graphic_figure graphicRef60831 \" href=\"UTD.htm?0/5/88\">",
"     figure 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. These symptoms are absent with small hemorrhages; the clinical presentation in this setting is that of a gradually progressing stroke.",
"   </p>",
"   <p>",
"    ICH destroys brain tissue as it enlarges. The pressure created by blood and surrounding brain edema is life-threatening; large hematomas have a high mortality and morbidity. The goal of treatment is to contain and limit the bleeding. Recurrences are unusual if the causative disorder is controlled (eg, hypertension or bleeding diathesis).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Subarachnoid hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two major causes of SAH are rupture of arterial aneurysms that lie at the base of the brain and bleeding from vascular malformations that lie near the pial surface. Bleeding diatheses, trauma, amyloid angiopathy, and illicit drug use are less common. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38522?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rupture of an aneurysm releases blood directly into the cerebrospinal fluid (CSF) under arterial pressure. The blood spreads quickly within the CSF, rapidly increasing intracranial pressure. Death or deep coma ensues if the bleeding continues. The bleeding usually lasts only a few seconds but rebleeding is very common. With causes of SAH other than aneurysm rupture, the bleeding is less abrupt and may continue over a longer period of time.",
"   </p>",
"   <p>",
"    Symptoms of SAH begin abruptly in contrast to the more gradual onset of ICH. The sudden increase in pressure causes a cessation of activity (eg, loss of memory or focus or knees buckling). Headache is an invariable symptom and is typically instantly severe and widespread; the pain may radiate into the neck or even down the back into the legs. Vomiting occurs soon after onset. There are usually no important focal neurologic signs unless bleeding occurs into the brain and CSF at the same time (meningocerebral hemorrhage). Onset headache is more common than in ICH, and the combination of onset headache and vomiting is infrequent in ischemic stroke (",
"    <a class=\"graphic graphic_figure graphicRef60831 \" href=\"UTD.htm?0/5/88\">",
"     figure 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38522?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Approximately 30 percent of patients have a minor hemorrhage manifested only by sudden and severe headache (the so-called sentinel headache) that precedes a major SAH (",
"    <a class=\"graphic graphic_figure graphicRef60831 \" href=\"UTD.htm?0/5/88\">",
"     figure 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/23\">",
"     23",
"    </a>",
"    ]. The complaint of the sudden onset of severe headache is sufficiently characteristic that a minor SAH should always be considered. In a prospective study of 148 patients presenting with sudden and severe headache, for example, subarachnoid hemorrhage was present in 25 percent overall and 12 percent in patients in whom headache was the only symptom [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9208/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The goal of treatment of SAH is to identify the cause and quickly treat it to prevent rebleeding. The other goal of treatment is to prevent brain damage due to delayed ischemia related to vasoconstriction of intracranial arteries; blood within the CSF induces vasoconstriction, which can be intense and severe. The treatment of SAH is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/54/37738?source=see_link\">",
"     \"Treatment of aneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?21/34/22050?source=see_link\">",
"       \"Patient information: Hemorrhagic stroke (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/55/24435?source=see_link\">",
"       \"Patient information: Stroke (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?37/37/38484?source=see_link\">",
"       \"Patient information: Stroke symptoms and diagnosis (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9208/abstract/1\">",
"      Caplan LR. Intracranial branch atheromatous disease: a neglected, understudied, and underused concept. Neurology 1989; 39:1246.",
"     </a>",
"    </li>",
"    <li>",
"     Caplan LR. Basic pathology, anatomy, and pathophysiology of stroke. In: Caplan's Stroke: A Clinical Approach, 4th ed, Saunders Elsevier, Philadelphia 2009. p.22.",
"    </li>",
"    <li>",
"     Caplan, LR, Manning, W (Eds). Brain embolism, Informa Healthcare, New York 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9208/abstract/4\">",
"      Caplan LR. Brain embolism, revisited. Neurology 1993; 43:1281.",
"     </a>",
"    </li>",
"    <li>",
"     Caplan, LR. Brain embolism. In: Clinical Neurocardiology, Caplan, LR, Hurst, JW, Chimowitz, M (Eds), Marcel Dekker, New York 1999. p.35.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9208/abstract/6\">",
"      Ay H, Furie KL, Singhal A, et al. An evidence-based causative classification system for acute ischemic stroke. Ann Neurol 2005; 58:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9208/abstract/7\">",
"      Doufekias E, Segal AZ, Kizer JR. Cardiogenic and aortogenic brain embolism. J Am Coll Cardiol 2008; 51:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9208/abstract/8\">",
"      Roach GW, Kanchuger M, Mangano CM, et al. Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med 1996; 335:1857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9208/abstract/9\">",
"      Flemming KD, Brown RD Jr, Petty GW, et al. Evaluation and management of transient ischemic attack and minor cerebral infarction. Mayo Clin Proc 2004; 79:1071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9208/abstract/10\">",
"      Meissner I, Khandheria BK, Sheps SG, et al. Atherosclerosis of the aorta: risk factor, risk marker, or innocent bystander? A prospective population-based transesophageal echocardiography study. J Am Coll Cardiol 2004; 44:1018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9208/abstract/11\">",
"      Petty GW, Khandheria BK, Meissner I, et al. Population-based study of the relationship between atherosclerotic aortic debris and cerebrovascular ischemic events. Mayo Clin Proc 2006; 81:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9208/abstract/12\">",
"      Russo C, Jin Z, Rundek T, et al. Atherosclerotic disease of the proximal aorta and the risk of vascular events in a population-based cohort: the Aortic Plaques and Risk of Ischemic Stroke (APRIS) study. Stroke 2009; 40:2313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9208/abstract/13\">",
"      Amarenco P, Duyckaerts C, Tzourio C, et al. The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 1992; 326:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9208/abstract/14\">",
"      Amarenco P, Cohen A, Tzourio C, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994; 331:1474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9208/abstract/15\">",
"      Cohen A, Tzourio C, Bertrand B, et al. Aortic plaque morphology and vascular events: a follow-up study in patients with ischemic stroke. FAPS Investigators. French Study of Aortic Plaques in Stroke. Circulation 1997; 96:3838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9208/abstract/16\">",
"      Di Tullio MR, Russo C, Jin Z, et al. Aortic arch plaques and risk of recurrent stroke and death. Circulation 2009; 119:2376.",
"     </a>",
"    </li>",
"    <li>",
"     Caplan LR. The aorta as a donor source of brain embolism. In: Brain embolism, Caplan, LR, Manning, WJ (Eds), Informa Healthcare, New York 2006. p.187.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9208/abstract/18\">",
"      Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9208/abstract/19\">",
"      Ay H, Benner T, Arsava EM, et al. A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System. Stroke 2007; 38:2979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9208/abstract/20\">",
"      Arsava EM, Ballabio E, Benner T, et al. The Causative Classification of Stroke system: an international reliability and optimization study. Neurology 2010; 75:1277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9208/abstract/21\">",
"      Caplan LR. Intracerebral haemorrhage. Lancet 1992; 339:656.",
"     </a>",
"    </li>",
"    <li>",
"     Kase, CS, Caplan, LR. Intracerebral hemorrhage, Butterworth-Heinemann, Boston 1996.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9208/abstract/23\">",
"      Gorelick PB, Hier DB, Caplan LR, Langenberg P. Headache in acute cerebrovascular disease. Neurology 1986; 36:1445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9208/abstract/24\">",
"      Linn FH, Wijdicks EF, van der Graaf Y, et al. Prospective study of sentinel headache in aneurysmal subarachnoid haemorrhage. Lancet 1994; 344:590.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1089 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-27.109.116.13-83254367CA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_63_9208=[""].join("\n");
var outline_f8_63_9208=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      BRAIN ISCHEMIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Thrombosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Large vessel disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Small vessel disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Embolism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - High-risk cardiac source",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Potential cardiac source",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Aortic atherosclerosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Systemic hypoperfusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Blood disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      TOAST classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H60049534\">",
"      SSS-TOAST and CCS classification",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      BRAIN HEMORRHAGE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Intracerebral hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Subarachnoid hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/1089\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1089|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/4/2122\" title=\"figure 1\">",
"      Cerebral arterial circulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/34/42531\" title=\"figure 2\">",
"      Cerebral vascular territories",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/62/9197\" title=\"figure 3\">",
"      Time course thrombotic stroke",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/54/25453\" title=\"figure 4\">",
"      Time course lacunar stroke",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/3/13373\" title=\"figure 5\">",
"      Time course embolic stroke",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/23/6526\" title=\"figure 6\">",
"      Time course cerebral hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/5/88\" title=\"figure 7\">",
"      Headache and vomiting in stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1089|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/39/21117\" title=\"table 1\">",
"      Ischemic stroke classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/43/21181\" title=\"table 2\">",
"      Cardioaortic sources embolism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/28/3531\" title=\"table 3\">",
"      TOAST classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/58/39853\" title=\"table 4\">",
"      SSS TOAST Classification",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/17/40216?source=related_link\">",
"      Clinical diagnosis of stroke subtypes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/10/40105?source=related_link\">",
"      Cryptogenic stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/21/18773?source=related_link\">",
"      Definition of transient ischemic attack",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/46/40678?source=related_link\">",
"      Etiology and clinical manifestations of transient ischemic attack",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/26/7594?source=related_link\">",
"      Etiology, clinical features, and diagnosis of cerebral venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38522?source=related_link\">",
"      Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/59/4026?source=related_link\">",
"      Lacunar infarcts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/47/3834?source=related_link\">",
"      Neurologic complications of cardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/47/28410?source=related_link\">",
"      Overview of the evaluation of stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/34/22050?source=related_link\">",
"      Patient information: Hemorrhagic stroke (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/55/24435?source=related_link\">",
"      Patient information: Stroke (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?37/37/38484?source=related_link\">",
"      Patient information: Stroke symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/33/32281?source=related_link\">",
"      Secondary prevention for specific causes of ischemic stroke and transient ischemic attack",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29130?source=related_link\">",
"      Spontaneous intracerebral hemorrhage: Pathogenesis, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/54/37738?source=related_link\">",
"      Treatment of aneurysmal subarachnoid hemorrhage",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_63_9209="Keratoderma blennorrhagicum 2";
var content_f8_63_9209=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F50133%7EDERM%2F73841&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F50133%7EDERM%2F73841&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Keratoderma blennorrhagicum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 434px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This close-up photograph shows the erythematous, scaly plaques of keratoderma blennorrhagicum in a patient with reactive arthritis (formerly Reiter's Syndrome).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Filip de Keyser.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Keratoderma blennorrhagicum in reactive arthritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple vesicles and pustules are present on the plantar foot of this patient with reactive arthritis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_63_9209=[""].join("\n");
var outline_f8_63_9209=null;
var title_f8_63_9210="Screening and diagnosis of diabetes mellitus during pregnancy";
var content_f8_63_9210=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Screening and diagnosis of diabetes mellitus during pregnancy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/63/9210/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/63/9210/contributors\">",
"     Donald R Coustan, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/63/9210/contributors\">",
"     Lois Jovanovic, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/63/9210/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/63/9210/contributors\">",
"     David M Nathan, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/63/9210/contributors\">",
"     Michael F Greene, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/63/9210/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/63/9210/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/63/9210/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy is characterized by insulin resistance and hyperinsulinemia, thus it may predispose some women to develop diabetes. The resistance stems from placental secretion of diabetogenic hormones including growth hormone, corticotropin releasing hormone, placental lactogen, and progesterone, as well as increased maternal adipose deposition, decreased exercise, and increased caloric intake. These and other endocrinologic and metabolic changes ensure that the fetus has an ample supply of fuel and nutrients at all times.",
"   </p>",
"   <p>",
"    Gestational diabetes occurs in women whose pancreatic function is not sufficient to secrete adequate amounts of additional insulin to overcome the insulin resistance created by changes in diabetogenic hormones during pregnancy. Among the main consequences of gestational diabetes are increased risks of preeclampsia, macrosomia, and cesarean delivery, and their associated morbidities. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/61/13274?source=see_link\">",
"     \"Maternal endocrine and metabolic adaptation to pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The approach to screening and diagnosis of diabetes in pregnancy will be reviewed here. Treatment and prognosis are discussed separately:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/62/37866?source=see_link\">",
"       \"Medical management and follow-up of gestational diabetes mellitus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/19/20794?source=see_link\">",
"       \"Medical management of type 1 and type 2 diabetes mellitus in pregnant women\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/13/4313?source=see_link\">",
"       \"Obstetrical management of pregnancies complicated by gestational diabetes mellitus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/62/35818?source=see_link\">",
"       \"Obstetrical management of pregnancy complicated by pregestational diabetes mellitus\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1818764\">",
"    <span class=\"h2\">",
"     Classic definition of gestational diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Historically, the term &ldquo;gestational diabetes&rdquo; has been used to define women with onset or first recognition of abnormal glucose tolerance during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/1\">",
"     1",
"    </a>",
"    ]. The American College of Obstetricians and Gynecologists (ACOG) continues to use this terminology [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7111897\">",
"    <span class=\"h2\">",
"     IADPSG definitions for overt and gestational diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 2010, the International Association of Diabetes and Pregnancy Study Group (IADPSG), an international consensus group with representatives from multiple obstetrical and diabetes organizations, recommended a change to the classic definition of gestational diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/3\">",
"     3",
"    </a>",
"    ]. In the proposed new system, diabetes diagnosed during pregnancy is classified as overt or gestational. In January 2011, the American Diabetes Association (ADA) endorsed this recommendation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/4\">",
"     4",
"    </a>",
"    ], and reaffirmed it in 2013 [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/5\">",
"     5",
"    </a>",
"    ]. This approach has not been endorsed by the American College of Obstetricians and Gynecologists (ACOG) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/2\">",
"     2",
"    </a>",
"    ] or in a March 2013 draft of findings from the National Institutes of Health (NIH) Consensus Development Conference on diagnosing gestational diabetes mellitus [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h3\">",
"     Overt diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;A diagnosis of overt diabetes can be made in women who meet any of the following criteria at their initial prenatal visit:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fasting plasma glucose &ge;126",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [7.0",
"      <span class=\"nowrap\">",
"       mmol/L],",
"      </span>",
"      or",
"     </li>",
"     <li>",
"      A1C &ge;6.5 percent using a standardized assay, or",
"     </li>",
"     <li>",
"      Random plasma glucose &ge;200",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [11.1",
"      <span class=\"nowrap\">",
"       mmol/]",
"      </span>",
"      that is subsequently confirmed by elevated fasting plasma glucose or A1C, as described above",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These thresholds were chosen because they correlate with development of adverse vascular events, such as retinopathy and coronary artery disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/54/38758?source=see_link\">",
"     \"Diagnosis of diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The rationale for this change is that an increasing proportion of young women have overt but as yet unrecognized type 2 diabetes due to the increasing prevalence of obesity and lack of routine glucose",
"    <span class=\"nowrap\">",
"     screening/testing",
"    </span>",
"    in this age group.",
"   </p>",
"   <p>",
"    In addition, about 10 percent of women formerly classified as having gestational diabetes have circulating islet-cell antibodies; these women may have a \"latent\" form of type 1 diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Their risk of developing type 1 diabetes is not known, but specific HLA alleles (DR3 or DR4) appear to predispose to the development of type 1 diabetes after delivery, as does the presence of islet-cell antibodies [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/9\">",
"     9",
"    </a>",
"    ]. Gestational diabetes in lean pregnant women, need for insulin treatment of gestational diabetes, diabetic ketoacidosis during pregnancy, and postpartum hyperglycemia also suggest preexisting unrecognized type 1 diabetes.",
"   </p>",
"   <p>",
"    Identifying overt diabetes early in pregnancy may be important because these women are at increased risk of having a child with a congenital anomaly and may be at increased risk of complications from diabetes (nephropathy, retinopathy) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. Early identification and treatment of hyperglycemia may reduce these risks. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/27/36281?source=see_link\">",
"     \"Pregnancy risks in women with type 1 and type 2 diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/19/20794?source=see_link\">",
"     \"Medical management of type 1 and type 2 diabetes mellitus in pregnant women\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    Because of variations in when women first present for prenatal care and when they are first tested, the diagnosis of overt diabetes probably applies to a broader group of women than those described in this narrow IADPSG definition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Gestational diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;A diagnosis of gestational diabetes can be made in women who meet either of the following criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fasting plasma glucose &ge;92",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [5.1",
"      <span class=\"nowrap\">",
"       mmol/L],",
"      </span>",
"      but &lt;126",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [7.0",
"      <span class=\"nowrap\">",
"       mmol/L]",
"      </span>",
"      at any gestational age (fasting plasma glucose &ge;126",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [7.0",
"      <span class=\"nowrap\">",
"       mmol/L]",
"      </span>",
"      is consistent with overt diabetes)",
"     </li>",
"     <li>",
"      At 24 to 28 weeks of gestation: 75 gram two hour oral glucose tolerance test (GTT) with at least one abnormal result: fasting plasma glucose &ge;92",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [5.1",
"      <span class=\"nowrap\">",
"       mmol/L],",
"      </span>",
"      but &lt;126",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [7.0",
"      <span class=\"nowrap\">",
"       mmol/L]",
"      </span>",
"      or one hour &ge;180",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (10.0",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      or two hour &ge;153",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (8.5",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      (",
"      <a class=\"graphic graphic_table graphicRef61208 \" href=\"UTD.htm?32/15/33019\">",
"       table 1",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The rationale for these thresholds is discussed below (see",
"    <a class=\"local\" href=\"#H5480972\">",
"     '75 gram two hour oral glucose tolerance test'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1819068\">",
"    <span class=\"h1\">",
"     PREVALENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of gestational diabetes as traditionally defined is at least 2 percent, and as high as 25 percent in some reports [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/13\">",
"     13",
"    </a>",
"    ]. The prevalence varies worldwide and among racial and ethnic groups, generally in step with the prevalence of type 2 diabetes. In the United States, prevalence rates are higher in African American, Hispanic American, Native American, and Asian women than in white women [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/14\">",
"     14",
"    </a>",
"    ]. Prevalence also varies because of differences in screening practices (universal versus selective screening), population characteristics (eg, average age and body mass index [BMI] of pregnant women), testing method, and diagnostic criteria. Prevalence has been increasing over time, possibly related to increases in mean maternal age and weight [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/15-17\">",
"     15-17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If IADPSG diagnostic criteria for overt and gestational diabetes are used, about 18 percent of women would be diagnosed with diabetes during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/3\">",
"     3",
"    </a>",
"    ]. While this estimate may seem quite high, it should be evaluated against the background risk of diabetes, estimated at 11.3 percent in 2011 [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/18\">",
"     18",
"    </a>",
"    ], and prediabetes, estimated to be at least 35 percent in 2008 [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/19\">",
"     19",
"    </a>",
"    ] in the United States adult population, age 20 years and above.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     SIGNIFICANCE OF DIABETES IN PREGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several adverse outcomes have been associated with diabetes during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/20-29\">",
"     20-29",
"    </a>",
"    ]. Importantly, the risk of these outcomes increases continuously as maternal fasting plasma glucose levels increase from the &le;75",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (4.2",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    range, and as the one hour and two hour oral GTT values increase; there is no clear threshold that defines patients at increased risk [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/21,30\">",
"     21,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adverse outcomes include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Preeclampsia",
"     </li>",
"     <li>",
"      Hydramnios",
"     </li>",
"     <li>",
"      Fetal macrosomia",
"     </li>",
"     <li>",
"      Fetal organomegaly (hepatomegaly, cardiomegaly)",
"     </li>",
"     <li>",
"      Birth trauma",
"     </li>",
"     <li>",
"      Operative delivery",
"     </li>",
"     <li>",
"      Perinatal mortality",
"     </li>",
"     <li>",
"      Neonatal respiratory problems and metabolic complications (hypoglycemia, hyperbilirubinemia, hypocalcemia, erythremia) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44809?source=see_link\">",
"       \"Infant of a diabetic mother\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If maternal hyperglycemia is present during organogenesis because of overt (also termed pregestational) diabetes, there are increased risks of miscarriage and congenital anomalies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/27/36281?source=see_link&amp;anchor=H5#H5\">",
"     \"Pregnancy risks in women with type 1 and type 2 diabetes mellitus\", section on 'Spontaneous abortion'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/27/36281?source=see_link&amp;anchor=H4#H4\">",
"     \"Pregnancy risks in women with type 1 and type 2 diabetes mellitus\", section on 'Congenital malformations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Potential long-term consequences to the infant of the diabetic mother include childhood obesity, impaired fine and gross motor functions, and higher rates of inattention",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hyperactivity [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. Importantly, these infants are at increased risk of developing diabetes later in life. In a long-term study of offspring of pregnancies complicated by gestational diabetes, the risk of diabetes or pre-diabetes at 18 to 27 years of age was increased eight-fold compared to the background population [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For the mother with gestational diabetes, there is a 10 percent likelihood of overt diabetes mellitus immediately after the index pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/34\">",
"     34",
"    </a>",
"    ]. This risk varies depending upon the diagnostic criteria used and her",
"    <span class=\"nowrap\">",
"     race/ethnicity.",
"    </span>",
"    The likelihood of developing overt diabetes in the years following the pregnancy has been estimated to be as high as 40 percent within 20 years [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/35\">",
"     35",
"    </a>",
"    ] and varies greatly depending upon characteristics such as geographic location, ethnicity, body mass index, and other risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     RISK FACTORS FOR DIABETES DURING PREGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnant women with any of the following appear to be at increased risk of developing gestational diabetes; the risk increases when multiple risk factors are present [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/37\">",
"     37",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A family history of diabetes, especially in first degree relatives [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/38\">",
"       38",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Prepregnancy weight &ge;110 percent of ideal body weight or body mass index &gt;30",
"      <span class=\"nowrap\">",
"       kg/m",
"       <sup>",
"        2",
"       </sup>",
"       ,",
"      </span>",
"      significant weight gain in early adulthood and between pregnancies [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/39\">",
"       39",
"      </a>",
"      ], or excessive gestational weight gain [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/40-42\">",
"       40-42",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Age &gt;25 years",
"     </li>",
"     <li>",
"      Previous delivery of a baby &gt;9 pounds [4.1 kg]",
"     </li>",
"     <li>",
"      Personal history of impaired glucose tolerance",
"     </li>",
"     <li>",
"      Member of an ethnic group with higher than the background rate of type 2 diabetes (eg, Hispanic-American, African-American, Native American, South or East Asian, Pacific Islander). In most populations, the background rate had been approximately 2 percent, but is rising rapidly.",
"     </li>",
"     <li>",
"      Previous unexplained perinatal loss or birth of a malformed infant",
"     </li>",
"     <li>",
"      Maternal birthweight &gt;9 pounds [4.1 kg] or &lt;6 pounds [2.7 kg]",
"     </li>",
"     <li>",
"      Glycosuria at the first prenatal visit",
"     </li>",
"     <li>",
"      Polycystic ovary syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/43-45\">",
"       43-45",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Current use of glucocorticoids",
"     </li>",
"     <li>",
"      Essential hypertension or pregnancy-related hypertension",
"     </li>",
"     <li>",
"      Metabolic syndrome",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Excessive weight gain in early to mid pregnancy has been associated with either having one abnormal value on a three hour GTT performed in the late second trimester [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/46-48\">",
"     46-48",
"    </a>",
"    ] or gestational diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/11/29882?source=see_link&amp;anchor=H10#H10\">",
"     \"The impact of obesity on fertility and pregnancy\", section on 'Gestational and pregestational diabetes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Women at low risk of gestational diabetes are younger, non-Hispanic white, with normal BMI (&lt;25",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"     ),",
"    </span>",
"    no history of previous glucose intolerance or adverse pregnancy outcomes associated with gestational diabetes, and no first degree relative with diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Approaches to reduce the risk of developing gestational diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;In overweight women, weight loss and an exercise program of brisk walking, stair climbing, or other vigorous activity before pregnancy and in early pregnancy may reduce the risk of developing gestational diabetes. &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Weight loss",
"      </strong>",
"      &mdash; The benefit of weight loss is illustrated by the following two examples:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In a population-based cohort study, obese women who lost at least 10 pounds (4.5 kgs) between pregnancies decreased their risk of gestational diabetes relative to women whose weight changed by less than 10 pounds (relative risk 0.63; 95% CI 0.38-1.02, adjusted for age and weight gain during each pregnancy) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study that compared the incidence of gestational diabetes in 346 women who delivered before bariatric surgery with the incidence in 354 women who delivered after bariatric surgery, the incidence of gestational diabetes was lower after bariatric surgery (8 versus 27 percent, OR 0.23, 95% CI 0.15-0.36) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/51\">",
"       51",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Exercise",
"      </strong>",
"      &mdash; Women who exercise regularly before and during early pregnancy may have a lower risk of developing gestational diabetes than less physically active women, similar to the effect of exercise for reducing the risk of type 2 diabetes mellitus in nonpregnant individuals. Observational studies support a benefit, but randomized trials have not. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29162?source=see_link&amp;anchor=H11#H11\">",
"       \"Prediction and prevention of type 2 diabetes mellitus\", section on 'Exercise'",
"      </a>",
"      .) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The value of physical activity was illustrated by a meta-analysis including seven prepregnancy and five early pregnancy studies (five prospective cohorts, two retrospective case-control studies, two cross-sectional studies) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/52\">",
"       52",
"      </a>",
"      ]. Women with the highest number of units of prepregnancy physical activity by self-report had approximately one half the risk of developing gestational diabetes as women with the lowest number of units (OR 0.45, 95% CI 0.28-0.75); units of physical activity reflected frequency (hours per week), energy expenditure (MET-hours per week),",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      level of exertion or intensity. Physical activity in early pregnancy was also protective (OR 0.76, 95%CI 0.70-0.83).",
"     </li>",
"     <li>",
"      In contrast, a meta-analysis of three randomized trials (n = 826 women) found that initiating an exercise program during pregnancy did not significantly reduce the risk of developing gestational diabetes compared with routine care (RR 1.10, 95% CI 0.66-1.84) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/53\">",
"       53",
"      </a>",
"      ]. This analysis was dominated by one large trial [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/54\">",
"       54",
"      </a>",
"      ] of 702 healthy normal weight women who underwent a 12-week exercise program beginning relatively late in pregnancy (ie, 18 to 22 weeks of gestation), which may have accounted for the lack of benefit. A randomized trial published after the meta-analysis also failed to show a reduction in gestational diabetes mellitus in women assigned to an exercise program in the second trimester [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/55\">",
"       55",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Few studies on the role of dietary factors in the development of gestational diabetes have been performed. Whether a diet low in red and processed meat, saturated fat, sugar sweetened soda, and refined grains reduces the risk of developing gestational diabetes is unproven [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/56\">",
"     56",
"    </a>",
"    ]. However, a healthy diet can promote weight loss, which is beneficial. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29162?source=see_link\">",
"     \"Prediction and prevention of type 2 diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A pilot study reported administration of the dietary supplement",
"    <em>",
"     myo",
"    </em>",
"    -inositol during pregnancy reduced the risk of developing gestational diabetes in a high risk population. In this open label trial, 220 nonobese gravidas at risk of gestational diabetes because of a first-degree relative with diabetes were randomly assigned to receive",
"    <em>",
"     myo",
"    </em>",
"    -inositol (2 g twice daily) plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    (400 mcg twice daily) or folic acid alone from the end of the first trimester throughout the remainder of the pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/57\">",
"     57",
"    </a>",
"    ]. Gestational diabetes (by",
"    <span class=\"nowrap\">",
"     IADPSG/ADA",
"    </span>",
"    criteria) developed in 6 percent of",
"    <em>",
"     myo",
"    </em>",
"    -inositol treated subjects versus 15 percent of control subjects (",
"    <em>",
"     P",
"    </em>",
"    = 0.04), fetal macrosomia was also reduced (0 versus 7 percent,",
"    <em>",
"     P",
"    </em>",
"    = 0.007) and average birth weight was 162 g lower in the treated group. Although promising, further studies need to be performed to determine the safety and efficacy of this intervention in the general pregnant population [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1818482\">",
"    <span class=\"h1\">",
"     BENEFITS AND HARMS OF SCREENING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefit of screening is that identifying pregnant women with diabetes followed by appropriate therapy can decrease fetal and maternal morbidity, particularly macrosomia, shoulder dystocia, and preeclampsia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/62/37866?source=see_link&amp;anchor=H2#H2\">",
"     \"Medical management and follow-up of gestational diabetes mellitus\", section on 'Rationale for treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    All of the commonly used screening and diagnostic tests involve drinking glucose-containing drinks",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    blood glucose measurement; none of these tests are associated with serious harmful maternal or fetal effects. However, some women find the hyperosmolar drinks difficult to tolerate. If gestational diabetes is diagnosed, management involves changes in diet, an increased frequency of prenatal visits, blood glucose monitoring, possible insulin therapy, and additional maternal and fetal monitoring.",
"   </p>",
"   <p>",
"    The cost implications of screening versus not screening and the most cost-effective screening approach have not been clearly determined [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/59-61\">",
"     59-61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SCREENING VERSUS DIAGNOSTIC TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The purpose of screening is to identify asymptomatic individuals with a high probability of having or developing a specific disease. Screening is usually performed as a two-step process where step one identifies individuals at increased risk for the disease so that step two, diagnostic testing, which is definitive but usually more complicated or costly than the screening test, can be limited to these individuals and avoided in low risk individuals. Alternatively, a diagnostic test can be administered to all individuals, which is a one-step process.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Two step approach",
"      </strong>",
"      -",
"      <strong>",
"      </strong>",
"      The two step approach is the most widely used approach for identifying pregnant women with diabetes in the United States, and is recommended by ACOG [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/62\">",
"       62",
"      </a>",
"      ]. It consists of a screening glucose challenge test, followed by a three hour oral GTT in screen positive patients.",
"     </li>",
"     <li>",
"      <strong>",
"       One step approach",
"      </strong>",
"      - The one step approach was proposed by the IADPSG and endorsed by the ADA [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/4,5\">",
"       4,5",
"      </a>",
"      ] and medical organizations in some countries, but not by ACOG [",
"      <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/2\">",
"       2",
"      </a>",
"      ]. It omits a screening test and simplifies diagnostic testing by performing a 75 gram two hour oral GTT and requiring only a single elevated value for diagnosis, rather than the previous three hour GTT requiring two elevated values for diagnosis. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3238377\">",
"    <span class=\"h2\">",
"     Whom to screen",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, universal screening appears to be the most practical approach because 90 percent of pregnant women have at least one risk factor for glucose impairment during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    ACOG recommends universal screening for gestational diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/2\">",
"     2",
"    </a>",
"    ]. The United States Preventive Services Task Force (USPSTF) and the Canadian Task Force on Preventive Health Care both concluded that there was insufficient evidence to recommend for or against universal screening for gestational diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. However, these recommendations were made prior to the publication of a second randomized trial demonstrating the benefit to diagnosing and treating mild gestational diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/66\">",
"     66",
"    </a>",
"    ]. The ADA endorses one-step diagnostic testing for gestational diabetes in all pregnant women (without pre-existing diabetes) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/5,67\">",
"     5,67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Organizations around the world are re-addressing their criteria for screening and diagnosis of diabetes in pregnant women based, in large part, on the recommendations of the IADPSG (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Significance of diabetes in pregnancy'",
"    </a>",
"    above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     When to screen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Universal screening has traditionally been performed at 24 to 28 weeks of gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Screening should be performed as early as the first prenatal visit if there is a high degree of suspicion that the pregnant woman has undiagnosed type 2 diabetes (eg, obesity, personal history of gestational diabetes, glycosuria, or strong family history of diabetes). In particular, women with a history of gestational diabetes have a 33 to 50 percent risk of recurrence, and some of these recurrences may represent unrecognized type 2 diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/62\">",
"     62",
"    </a>",
"    ]. Early screening or diagnostic testing is consistent with the IADPSG&rsquo;s new terminology and recommendations for diagnosis of diabetes in pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Definitions'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H17\">",
"     'One step approach'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     How to screen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systematic reviews have not determined the best strategy for screening and diagnosis of gestational diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/13,69\">",
"     13,69",
"    </a>",
"    ]. There is no worldwide standard for screening and diagnosis of diabetes during pregnancy (",
"    <a class=\"graphic graphic_table graphicRef87282 \" href=\"UTD.htm?26/35/27198\">",
"     table 2",
"    </a>",
"    ). In the United States, the current approach is screening with a glucose challenge test, followed by diagnostic testing in women who screen positive (ie, two step approach) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3156457\">",
"    <span class=\"h3\">",
"     Two step approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;This approach begins with a 50 gram oral glucose challenge test for screening (",
"    <a class=\"graphic graphic_table graphicRef78433 \" href=\"UTD.htm?8/24/8587\">",
"     table 3",
"    </a>",
"    ). The 50 gram oral glucose load is given without regard to the time elapsed since the last meal and plasma glucose is measured one hour later (sometimes called a \"one-hour GTT\"); a value &ge;130 or &ge;140",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (7.2 or 7.8",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    is considered abnormal (see below); we use &ge;130",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    as the threshold for our patients. Screening and diagnostic tests that measure glucose concentration should be performed on venous plasma using an accurate and precise enzymatic method. &nbsp;",
"   </p>",
"   <p>",
"    The original threshold for an abnormal test (&ge;140",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    was arbitrary and validated by the ability to predict a positive three-hour oral GTT in the mother. However, the sensitivity of the 50 gram glucose challenge test is improved if a lower plasma glucose threshold (&ge;130",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    is used [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/70,71\">",
"     70,71",
"    </a>",
"    ]. At the 130",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    threshold, sensitivity and specificity are 99 and 77 percent, respectively (when validated against",
"    <span class=\"nowrap\">",
"     Carpenter/Coustan",
"    </span>",
"    and ADA criteria for diagnosis of gestational diabetes); at the 140",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    threshold, sensitivity is lower (85 percent) but specificity is higher (86 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/13\">",
"     13",
"    </a>",
"    ]. Based on these findings, ACOG has stated that either threshold may be used. Women with an abnormal value are then given a 100 gram three hour oral GTT for definitive diagnosis (see",
"    <a class=\"local\" href=\"#H20\">",
"     'Glucose tolerance test'",
"    </a>",
"    below) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     One step approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The IADPSG felt that the decision to",
"    <span class=\"nowrap\">",
"     screen/test",
"    </span>",
"    for diabetes at the first prenatal visit should be based upon the background frequency of abnormal glucose metabolism in the population and on local circumstances. Given the increasing frequency of type 2 diabetes in the US population, universal early testing when routine initial prenatal laboratory tests are drawn is both desirable and convenient.",
"   </p>",
"   <p>",
"    We suggest universal testing at the initial prenatal visit by obtaining an A1C, since women are unlikely to be fasting at this visit. This approach has not yet been validated by data from randomized trials. It is endorsed by the ADA [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/4,5\">",
"     4,5",
"    </a>",
"    ], but not by ACOG [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/2\">",
"     2",
"    </a>",
"    ]. ACOG noted that, by the IADPSG estimate, 18 percent of all pregnant women will be diagnosed with gestational diabetes. They opined that the one step approach would increase health care costs in the absence of evidence that use of the IADPSG approach and criteria result in improvements in maternal or newborn outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As discussed above (see",
"    <a class=\"local\" href=\"#H3\">",
"     'Overt diabetes'",
"    </a>",
"    above), a diagnosis of overt diabetes is made in women who meet any of the following criteria at their initial prenatal visit:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Fasting plasma glucose &ge;126",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [7.0",
"      <span class=\"nowrap\">",
"       mmol/L],",
"      </span>",
"      or",
"     </li>",
"     <li>",
"      A1C &ge;6.5 percent using a standardized assay, or",
"     </li>",
"     <li>",
"      Random plasma glucose &ge;200",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [11.1",
"      <span class=\"nowrap\">",
"       mmol/]",
"      </span>",
"      that is subsequently confirmed by elevated fasting plasma glucose or A1C, as described above",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because of variations in when women first present for prenatal care and when they are first tested, the diagnosis of overt diabetes probably applies to a broader group of women than those described in the narrow IADPSG definition.",
"   </p>",
"   <p>",
"    A diagnosis of gestational diabetes is made at the initial prenatal visit if the fasting plasma glucose is &ge;92",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [5.1",
"    <span class=\"nowrap\">",
"     mmol/L],",
"    </span>",
"    but &lt;126",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [7.0",
"    <span class=\"nowrap\">",
"     mmol/L].",
"    </span>",
"    (Fasting plasma glucose &ge;126",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [7.0",
"    <span class=\"nowrap\">",
"     mmol/L]",
"    </span>",
"    is consistent with overt diabetes). Since most women will not be fasting when their blood is drawn, this diagnosis will rarely be made.",
"   </p>",
"   <p>",
"    When overt diabetes or gestational diabetes has not been diagnosed with initial testing at the first prenatal visit, a 75 gram two hour oral GTT should be administered at 24 to 28 weeks of gestation to all patients (",
"    <a class=\"graphic graphic_table graphicRef61208 \" href=\"UTD.htm?32/15/33019\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef64477 \" href=\"UTD.htm?2/4/2127\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Glucose tolerance test'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     GLUCOSE TOLERANCE TEST",
"    </span>",
"    &nbsp;&mdash;&nbsp;The oral GTT is an imprecise test with poor reproducibility [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/73\">",
"     73",
"    </a>",
"    ]. A study that performed two oral GTTs one to two weeks apart in 64 pregnant women whose 50 gram glucose challenge was greater than 135",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    found 48 had",
"    <span class=\"nowrap\">",
"     normal/normal,",
"    </span>",
"    11 had",
"    <span class=\"nowrap\">",
"     normal/abnormal,",
"    </span>",
"    3 had",
"    <span class=\"nowrap\">",
"     abnormal/normal,",
"    </span>",
"    and 2 had",
"    <span class=\"nowrap\">",
"     abnormal/abnormal",
"    </span>",
"    results [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/74\">",
"     74",
"    </a>",
"    ]. Thus, only",
"    <span class=\"nowrap\">",
"     50/64",
"    </span>",
"    (78 percent) had reproducible test results. Nevertheless, it is a practical means of diagnosing gestational diabetes.",
"   </p>",
"   <p>",
"    The GTT can be omitted in women with a markedly elevated random glucose concentration (&gt;200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [11.1",
"    <span class=\"nowrap\">",
"     mmol/L]),",
"    </span>",
"    given the high probability these women will have an abnormal GTT [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/75,76\">",
"     75,76",
"    </a>",
"    ]. This avoids the extreme hyperglycemia that may be induced by a GTT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5480965\">",
"    <span class=\"h2\">",
"     100 gram three hour oral glucose tolerance test",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 100 gram three hour oral GTT is most commonly used during pregnancy in the United States and is currently recommended by ACOG; two elevated glucose values are needed for a positive test (",
"    <a class=\"graphic graphic_table graphicRef80677 \" href=\"UTD.htm?17/32/17932\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/3,62,70,77,78\">",
"     3,62,70,77,78",
"    </a>",
"    ]. Carbohydrate loading for three days has been recommended before this test, but is probably not necessary if the patient is not on a low carbohydrate diet [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/79-82\">",
"     79-82",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5480972\">",
"    <span class=\"h2\">",
"     75 gram two hour oral glucose tolerance test",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 75 gram two hour oral GTT is recommended by the IADPSG and ADA (",
"    <a class=\"graphic graphic_table graphicRef61208 \" href=\"UTD.htm?32/15/33019\">",
"     table 1",
"    </a>",
"    ) as it is more convenient, better tolerated, and more sensitive for identifying the pregnancy at risk for adverse outcome than the 100 gram three hour oral GTT. Increased sensitivity is likely related to a lower threshold for a positive test &ndash; only one elevated glucose value is needed and the cut-offs are slightly lower.",
"   </p>",
"   <p>",
"    This conclusion is supported by results from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study, a prospective observational study of more than 23,000 pregnancies evaluated with a 75 gram two hour oral GTT [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/21\">",
"     21",
"    </a>",
"    ]. The investigators found a continuum of increasing risk of adverse outcome as each of the three (fasting, one-hour, and two-hour) plasma glucose values increased. These adverse outcomes included macrosomia, cesarean delivery, neonatal hypoglycemia, and preeclampsia.",
"   </p>",
"   <p>",
"    The IADPSG defined thresholds for the 75 gram two hour oral GTT based on outcome data reported in the HAPO study [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/3,21\">",
"     3,21",
"    </a>",
"    ]. These thresholds represent the glucose values at which the odds of infant birth weight, cord C-peptide (proxy for fetal insulin level), and percent body fat &gt;90 percentile were 1.75 times the estimated odds of these outcomes at mean glucose levels, based on fully adjusted logistic regression models. Compared to women in the HAPO study with all glucose values below the thresholds, women who exceeded one or more of these thresholds had a two-fold higher frequency of large for gestational age infants and preeclampsia, and &gt;45 percent increase in preterm delivery and primary cesarean delivery. Using an odds ratio of 2 for the thresholds defined a population with a higher frequency of these outcomes, but the difference was modest and resulted in failure to identify many women who were at almost comparable risk.",
"   </p>",
"   <p>",
"    While more research will be necessary as the IADPSG criteria come into use around the world, two randomized trials [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/66,83\">",
"     66,83",
"    </a>",
"    ] have demonstrated that identification and treatment of even mild gestational diabetes can improve outcomes. Retrospective studies that evaluated pregnancy outcome with the new diagnostic criteria reached discordant conclusions about their value [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/84-86\">",
"     84-86",
"    </a>",
"    ] (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/62/37866?source=see_link\">",
"     \"Medical management and follow-up of gestational diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5480735\">",
"    <span class=\"h1\">",
"     PATIENTS UNABLE TO TOLERATE ORAL HYPEROSMOLAR GLUCOSE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3830491\">",
"    <span class=\"h2\">",
"     Test alternatives to the GCT and GTT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The highly concentrated hyperosmolar glucose solution used for the GCT and GTT can cause gastric irritation, delayed emptying, and gastrointestinal osmotic imbalance, leading to nausea and vomiting. Alternatives to the oral screening and glucose tolerance tests have been proposed and are better tolerated, but appear to be less sensitive and have not been validated in large studies. These approaches typically use candy, a predefined meal, or commercial soft drinks instead of a standard glucose monomer or polymer solution [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/87-91\">",
"     87-91",
"    </a>",
"    ]. None have been endorsed by the ADA or ACOG.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5480742\">",
"    <span class=\"h2\">",
"     Serial glucose monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Periodic random fasting and two-hour postprandial blood glucose testing is a monitoring option for women at high risk for gestational diabetes who are unable to tolerate an oral glucose load. This approach is also useful for women who have dumping syndrome after a roux-en-Y gastric bypass procedure; these women are unlikely to tolerate a hyperosmolar glucose solution [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/92\">",
"     92",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/18/27945?source=see_link\">",
"     \"Fertility and pregnancy after bariatric surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5480749\">",
"    <span class=\"h2\">",
"     Intravenous GTT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The intravenous GTT is an alternative for patients who cannot tolerate an oral glucose load [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/93,94\">",
"     93,94",
"    </a>",
"    ]. While it is not a standard approach or widely used, one author (DC) has found this test to be useful in these patients. The test dose of 25 grams of glucose is rapidly infused intravenously. Plasma glucose is measured prior to the infusion, at 10 minutes and at 60 minutes. The 10-minute plasma glucose value is divided by the 60-minute glucose value to arrive at a quotient (Q) describing the rate of disappearance of glucose from the circulation. Nondiabetic individuals will clear glucose more rapidly than those with diabetes. A table can be used to convert the Q to a k value, which represents the slope of the glucose disappearance curve (",
"    <a class=\"graphic graphic_table graphicRef66319 \" href=\"UTD.htm?13/0/13327\">",
"     table 5",
"    </a>",
"    ). The lower limit of normal (mean &ndash; 2 standard deviations) k values was found to be 1.37 in the first trimester, 1.18 in the second trimester, and 1.13 in the third trimester [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/95,96\">",
"     95,96",
"    </a>",
"    ]. While this approach has not been well validated against oral GTT results, nor against pregnancy outcome, the author has found it useful in those patients who cannot tolerate the oral glucose load.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5480756\">",
"    <span class=\"h2\">",
"     A1C",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a large overlap in the distribution of A1C values between women with normal, borderline abnormal, and mildly abnormal blood glucose levels. Therefore, A1C is",
"    <strong>",
"     not",
"    </strong>",
"    a suitable test to detect mildly impaired glucose tolerance. An A1C &ge;6.5 percent suggests type 2 diabetes, and is one of the criteria for diagnosis of overt diabetes in pregnancy proposed by the IADPSG and endorsed by the ADA (see",
"    <a class=\"local\" href=\"#H2\">",
"     'Definitions'",
"    </a>",
"    above). In fact, data are accruing that an A1C level greater than two standard deviations above the normal mean during pregnancy, when A1C levels are generally slightly lower than in the nonpregnant state (in most laboratories this level is approximately 5.3 percent), may identify those women at risk for delivering a large for gestational age infant [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/97,98\">",
"     97,98",
"    </a>",
"    ]. However, an A1C below this level should not be taken as evidence against the diagnosis of diabetes and cannot substitute for an oral GTT [",
"    <a class=\"abstract\" href=\"UTD.htm?8/63/9210/abstract/99\">",
"     99",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/46/12002?source=see_link\">",
"       \"Patient information: Gestational diabetes (diabetes that starts during pregnancy) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?32/13/32979?source=see_link\">",
"       \"Patient information: Gestational diabetes mellitus (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The terminology for diabetes diagnosed in pregnancy is in flux. The terms overt and gestational diabetes are based on gestational age at diagnosis and degree of glucose abnormality. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definitions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diabetes during pregnancy is associated with several adverse outcomes for both mother and child, including preeclampsia, macrosomia, and cesarean delivery, and their associated morbidities. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Significance of diabetes in pregnancy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Major organizations have not reached consensus regarding universal screening for diabetes in pregnancy or the best diagnostic test. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Screening versus diagnostic testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest screening for diabetes during pregnancy (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1818482\">",
"       'Benefits and harms of screening'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      We suggest universal screening, rather than selective screening based upon risk factors (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3238377\">",
"       'Whom to screen'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'One step approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We obtain an A1C level at the initial prenatal visit. If &lt;6.5 percent, we perform a 75 gram two hour oral GTT at 24 to 28 weeks of gestation (",
"      <a class=\"graphic graphic_table graphicRef61208 \" href=\"UTD.htm?32/15/33019\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H17\">",
"       'One step approach'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5480972\">",
"       '75 gram two hour oral glucose tolerance test'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      A two step approach (ie, a 50 gram glucose challenge screening test at 24 to 28 weeks followed by a 100 gram three hour oral GTT (",
"      <a class=\"graphic graphic_table graphicRef80677 \" href=\"UTD.htm?17/32/17932\">",
"       table 4",
"      </a>",
"      )) in screen positive patients (glucose &ge;130 or &ge;140",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [7.2 or 7.8",
"      <span class=\"nowrap\">",
"       mmol/L])",
"      </span>",
"      is also an acceptable approach. (See",
"      <a class=\"local\" href=\"#H3156457\">",
"       'Two step approach'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5480965\">",
"       '100 gram three hour oral glucose tolerance test'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Some women do not tolerate the highly concentrated hyperosmolar glucose solution used for the oral GTT. Other types of",
"      <span class=\"nowrap\">",
"       screening/testing",
"      </span>",
"      methods are available, but appear to be less sensitive and have not been validated in large studies. (See",
"      <a class=\"local\" href=\"#H5480735\">",
"       'Patients unable to tolerate oral hyperosmolar glucose'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/1\">",
"      Proceedings of the 4th International Workshop-Conference on Gestational Diabetes Mellitus. Chicago, Illinois, USA. 14-16 March 1997. Diabetes Care 1998; 21 Suppl 2:B1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/2\">",
"      Committee opinion no. 504: screening and diagnosis of gestational diabetes mellitus. Obstet Gynecol 2011; 118:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/3\">",
"      International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/4\">",
"      American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34 Suppl 1:S62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/5\">",
"      American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013; 36 Suppl 1:S67.",
"     </a>",
"    </li>",
"    <li>",
"     Draft statement March 6, 2103. NATIONAL INSTITUTES OF HEALTH CONSENSUS DEVELOPMENT CONFERENCE STATEMENT National Institutes of Health Consensus Development Conference: Diagnosing Gestational Diabetes Mellitus Conference",
"March 4&ndash;6, 2013 file://prevention.nih.gov/cdp/conferences/2013/gdm/files/DraftStatement.pdf (Accessed on March 25, 2013).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/7\">",
"      Mauricio D, Balsells M, Morales J, et al. Islet cell autoimmunity in women with gestational diabetes and risk of progression to insulin-dependent diabetes mellitus. Diabetes Metab Rev 1996; 12:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/8\">",
"      J&auml;rvel&auml; IY, Juutinen J, Koskela P, et al. Gestational diabetes identifies women at risk for permanent type 1 and type 2 diabetes in fertile age: predictive role of autoantibodies. Diabetes Care 2006; 29:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/9\">",
"      Ferber KM, Keller E, Albert ED, Ziegler AG. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes. J Clin Endocrinol Metab 1999; 84:2342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/10\">",
"      Schaefer UM, Songster G, Xiang A, et al. Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy. Am J Obstet Gynecol 1997; 177:1165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/11\">",
"      Omori Y, Jovanovic L. Proposal for the reconsideration of the definition of gestational diabetes. Diabetes Care 2005; 28:2592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/12\">",
"      Sheffield JS, Butler-Koster EL, Casey BM, et al. Maternal diabetes mellitus and infant malformations. Obstet Gynecol 2002; 100:925.",
"     </a>",
"    </li>",
"    <li>",
"     Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Aktary WM, Pasichnyk D, Seida JC, Donovan L. Screening and Diagnosing Gestational Diabetes Mellitus. Evidence Report/Technology Assessment No. 210. (Prepared by the University of Alberta Evidence-based Practice Center under Contract No. 290-2007-10021-I.) AHRQ Publication No. 12(13)-E021-EF. Rockville, MD: Agency for Healthcare Research and Quality. October 2012 www.effectivehealthcare.ahrq.gov/reports/final.cfm. (Accessed on November 30, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/14\">",
"      Anna V, van der Ploeg HP, Cheung NW, et al. Sociodemographic correlates of the increasing trend in prevalence of gestational diabetes mellitus in a large population of women between 1995 and 2005. Diabetes Care 2008; 31:2288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/15\">",
"      Dabelea D, Snell-Bergeon JK, Hartsfield CL, et al. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 2005; 28:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/16\">",
"      Getahun D, Nath C, Ananth CV, et al. Gestational diabetes in the United States: temporal trends 1989 through 2004. Am J Obstet Gynecol 2008; 198:525.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/17\">",
"      Albrecht SS, Kuklina EV, Bansil P, et al. Diabetes trends among delivery hospitalizations in the U.S., 1994-2004. Diabetes Care 2010; 33:768.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011. file://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf (Accessed on March 25, 2013).",
"    </li>",
"    <li>",
"     National Diabetes Information Clearinghouse. National Diabetes Statistics, 2007. file://diabetes.niddk.nih.gov/dm/pubs/statistics/",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/20\">",
"      Dodd JM, Crowther CA, Antoniou G, et al. Screening for gestational diabetes: the effect of varying blood glucose definitions in the prediction of adverse maternal and infant health outcomes. Aust N Z J Obstet Gynaecol 2007; 47:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/21\">",
"      HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358:1991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/22\">",
"      Jensen DM, Damm P, S&oslash;rensen B, et al. Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus. Am J Obstet Gynecol 2001; 185:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/23\">",
"      Ferrara A, Weiss NS, Hedderson MM, et al. Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the National Diabetes Data Group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycaemia and hyperbilirubinaemia. Diabetologia 2007; 50:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/24\">",
"      Pettitt DJ, Knowler WC, Baird HR, Bennett PH. Gestational diabetes: infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians. Diabetes Care 1980; 3:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/25\">",
"      Jensen DM, Korsholm L, Ovesen P, et al. Adverse pregnancy outcome in women with mild glucose intolerance: is there a clinically meaningful threshold value for glucose? Acta Obstet Gynecol Scand 2008; 87:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/26\">",
"      Sermer M, Naylor CD, Gare DJ, et al. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol 1995; 173:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/27\">",
"      Sacks DA, Greenspoon JS, Abu-Fadil S, et al. Toward universal criteria for gestational diabetes: the 75-gram glucose tolerance test in pregnancy. Am J Obstet Gynecol 1995; 172:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/28\">",
"      Pettitt DJ, Knowler WC. Long-term effects of the intrauterine environment, birth weight, and breast-feeding in Pima Indians. Diabetes Care 1998; 21 Suppl 2:B138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/29\">",
"      Hillier TA, Pedula KL, Schmidt MM, et al. Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care 2007; 30:2287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/30\">",
"      Landon MB, Mele L, Spong CY, et al. The relationship between maternal glycemia and perinatal outcome. Obstet Gynecol 2011; 117:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/31\">",
"      Ornoy A. Growth and neurodevelopmental outcome of children born to mothers with pregestational and gestational diabetes. Pediatr Endocrinol Rev 2005; 3:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/32\">",
"      Dabelea D. The predisposition to obesity and diabetes in offspring of diabetic mothers. Diabetes Care 2007; 30 Suppl 2:S169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/33\">",
"      Clausen TD, Mathiesen ER, Hansen T, et al. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care 2008; 31:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/34\">",
"      Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 2005; 115:485.",
"     </a>",
"    </li>",
"    <li>",
"     O'Sullivan, JB. Subsequent morbidity among gestational diabetic women. In: Carbohydrate metabolism in pregnancy and the newborn, Sutherland, HPWP, Stowers, JM (Eds), Churchill Livingstone, New York 1984. p.174.",
"    </li>",
"    <li>",
"     Mestman, JH. Interaction between pregnancy, gestational diabetes, and long-term maternal outcome. In: Diabetes in Women, 3rd, Reece, EA, Coustan, DR, Gabbe, SG (Eds), Lippincott, Williams and Wilkins, Philadelphia 2004. p.233.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/37\">",
"      Solomon CG, Willett WC, Carey VJ, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 1997; 278:1078.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/38\">",
"      Kim C, Liu T, Valdez R, Beckles GL. Does frank diabetes in first-degree relatives of a pregnant woman affect the likelihood of her developing gestational diabetes mellitus or nongestational diabetes? Am J Obstet Gynecol 2009; 201:576.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/39\">",
"      Hedderson MM, Williams MA, Holt VL, et al. Body mass index and weight gain prior to pregnancy and risk of gestational diabetes mellitus. Am J Obstet Gynecol 2008; 198:409.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/40\">",
"      Hedderson MM, Gunderson EP, Ferrara A. Gestational weight gain and risk of gestational diabetes mellitus. Obstet Gynecol 2010; 115:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/41\">",
"      Gibson KS, Waters TP, Catalano PM. Maternal weight gain in women who develop gestational diabetes mellitus. Obstet Gynecol 2012; 119:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/42\">",
"      Carreno CA, Clifton RG, Hauth JC, et al. Excessive early gestational weight gain and risk of gestational diabetes mellitus in nulliparous women. Obstet Gynecol 2012; 119:1227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/43\">",
"      Toulis KA, Goulis DG, Kolibianakis EM, et al. Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Fertil Steril 2009; 92:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/44\">",
"      Glueck CJ, Wang P, Kobayashi S, et al. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002; 77:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/45\">",
"      Begum MR, Khanam NN, Quadir E, et al. Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome. J Obstet Gynaecol Res 2009; 35:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/46\">",
"      Herring SJ, Oken E, Rifas-Shiman SL, et al. Weight gain in pregnancy and risk of maternal hyperglycemia. Am J Obstet Gynecol 2009; 201:61.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/47\">",
"      Saldana TM, Siega-Riz AM, Adair LS, Suchindran C. The relationship between pregnancy weight gain and glucose tolerance status among black and white women in central North Carolina. Am J Obstet Gynecol 2006; 195:1629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/48\">",
"      Tovar A, Must A, Bermudez OI, et al. The impact of gestational weight gain and diet on abnormal glucose tolerance during pregnancy in Hispanic women. Matern Child Health J 2009; 13:520.",
"     </a>",
"    </li>",
"    <li>",
"     Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Aktary WM,",
"Pasichnyk D, Seida JC, Donovan L. Screening and Diagnosing Gestational Diabetes Mellitus.",
"Evidence Report/Technology Assessment No. 210. (Prepared by the University of Alberta",
"Evidence-based Practice Center under Contract No. 290-2007-10021-I.) AHRQ Publication No.",
"12(13)-E021-EF. Rockville, MD: Agency for Healthcare Research and Quality. October 2012. www.effectivehealthcare.ahrq.gov/reports/final.cfm. (Accessed on November 30, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/50\">",
"      Glazer NL, Hendrickson AF, Schellenbaum GD, Mueller BA. Weight change and the risk of gestational diabetes in obese women. Epidemiology 2004; 15:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/51\">",
"      Burke AE, Bennett WL, Jamshidi RM, et al. Reduced incidence of gestational diabetes with bariatric surgery. J Am Coll Surg 2010; 211:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/52\">",
"      Tobias DK, Zhang C, van Dam RM, et al. Physical activity before and during pregnancy and risk of gestational diabetes mellitus: a meta-analysis. Diabetes Care 2011; 34:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/53\">",
"      Han S, Middleton P, Crowther CA. Exercise for pregnant women for preventing gestational diabetes mellitus. Cochrane Database Syst Rev 2012; :CD009021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/54\">",
"      Stafne SN, Salvesen K&Aring;, Romundstad PR, et al. Regular exercise during pregnancy to prevent gestational diabetes: a randomized controlled trial. Obstet Gynecol 2012; 119:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/55\">",
"      Barakat R, Pelaez M, Lopez C, et al. Exercise during pregnancy and gestational diabetes-related adverse effects: a randomised controlled trial. Br J Sports Med 2013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/56\">",
"      Zhang C, Ning Y. Effect of dietary and lifestyle factors on the risk of gestational diabetes: review of epidemiologic evidence. Am J Clin Nutr 2011; 94:1975S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/57\">",
"      D'Anna R, Scilipoti A, Giordano D, et al. myo-Inositol Supplementation and Onset of Gestational Diabetes Mellitus in Pregnant Women With a Family History of Type 2 Diabetes: A prospective, randomized, placebo-controlled study. Diabetes Care 2013; 36:854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/58\">",
"      Coustan DR. Can a dietary supplement prevent gestational diabetes mellitus? Diabetes Care 2013; 36:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/59\">",
"      Meltzer SJ, Snyder J, Penrod JR, et al. Gestational diabetes mellitus screening and diagnosis: a prospective randomised controlled trial comparing costs of one-step and two-step methods. BJOG 2010; 117:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/60\">",
"      Werner EF, Pettker CM, Zuckerwise L, et al. Screening for gestational diabetes mellitus: are the criteria proposed by the international association of the Diabetes and Pregnancy Study Groups cost-effective? Diabetes Care 2012; 35:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/61\">",
"      Holt RI, Coleman MA, McCance DR. The implications of the new International Association of Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria for gestational diabetes. Diabet Med 2011; 28:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/62\">",
"      American College of Obstetricians and Gynecologists Committee on Practice Bulletins--Obstetrics. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol 2001; 98:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/63\">",
"      Danilenko-Dixon DR, Van Winter JT, Nelson RL, Ogburn PL Jr. Universal versus selective gestational diabetes screening: application of 1997 American Diabetes Association recommendations. Am J Obstet Gynecol 1999; 181:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/64\">",
"      U.S. Preventive Services Task Force. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 148:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/65\">",
"      Periodic health examination, 1992 update: 1. Screening for gestational diabetes mellitus. Canadian Task Force on the Periodic Health Examination. CMAJ 1992; 147:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/66\">",
"      Landon MB, Spong CY, Thom E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009; 361:1339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/67\">",
"      American Diabetes Association. Standards of medical care in diabetes--2013. Diabetes Care 2013; 36 Suppl 1:S11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/68\">",
"      Jovanovic L, Peterson CM. Screening for gestational diabetes. Optimum timing and criteria for retesting. Diabetes 1985; 34 Suppl 2:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/69\">",
"      Farrar D, Duley L, Lawlor DA. Different strategies for diagnosing gestational diabetes to improve maternal and infant health. Cochrane Database Syst Rev 2011; :CD007122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/70\">",
"      Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/71\">",
"      Coustan DR, Widness JA, Carpenter MW, et al. Should the fifty-gram, one-hour plasma glucose screening test for gestational diabetes be administered in the fasting or fed state? Am J Obstet Gynecol 1986; 154:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/72\">",
"      O'SULLIVAN JB, MAHAN CM. CRITERIA FOR THE ORAL GLUCOSE TOLERANCE TEST IN PREGNANCY. Diabetes 1964; 13:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/73\">",
"      Riccardi G, Vaccaro O, Rivellese A, et al. Reproducibility of the new diagnostic criteria for impaired glucose tolerance. Am J Epidemiol 1985; 121:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/74\">",
"      Harlass FE, Brady K, Read JA. Reproducibility of the oral glucose tolerance test in pregnancy. Am J Obstet Gynecol 1991; 164:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/75\">",
"      Shivvers SA, Lucas MJ. Gestational diabetes. Is a 50-g screening result &gt; or = 200 mg/dL diagnostic? J Reprod Med 1999; 44:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/76\">",
"      Ramos GA, Jacobson GF, Kirby RS, et al. Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia. J Perinatol 2007; 27:262.",
"     </a>",
"    </li>",
"    <li>",
"     Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 1998 Aug 21 Suppl 2.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/78\">",
"      Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000; 23 Suppl 1:S4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/79\">",
"      Conn, JW. Interpretation of the glucose tolerance test: necessity of standard preparatory diet. Am J Med Sci 1940; 199:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/80\">",
"      Crowe SM, Mastrobattista JM, Monga M. Oral glucose tolerance test and the preparatory diet. Am J Obstet Gynecol 2000; 182:1052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/81\">",
"      Entrekin K, Work B, Owen J. Does a high carbohydrate preparatory diet affect the 3-hour oral glucose tolerance test in pregnancy? J Matern Fetal Med 1998; 7:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/82\">",
"      Harlass FE, McClure GB, Read JA, Brady K. Use of a standard preparatory diet for the oral glucose tolerance test. Is it necessary? J Reprod Med 1991; 36:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/83\">",
"      Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352:2477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/84\">",
"      O'Sullivan EP, Avalos G, O'Reilly M, et al. Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria. Diabetologia 2011; 54:1670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/85\">",
"      Lapolla A, Dalfr&agrave; MG, Ragazzi E, et al. New International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recommendations for diagnosing gestational diabetes compared with former criteria: a retrospective study on pregnancy outcome. Diabet Med 2011; 28:1074.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/86\">",
"      Bodmer-Roy S, Morin L, Cousineau J, Rey E. Pregnancy outcomes in women with and without gestational diabetes mellitus according to the International Association of the Diabetes and Pregnancy Study Groups criteria. Obstet Gynecol 2012; 120:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/87\">",
"      Lamar ME, Kuehl TJ, Cooney AT, et al. Jelly beans as an alternative to a fifty-gram glucose beverage for gestational diabetes screening. Am J Obstet Gynecol 1999; 181:1154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/88\">",
"      Murphy NJ, Meyer BA, O'Kell RT, Hogard ME. Carbohydrate sources for gestational diabetes mellitus screening. A comparison. J Reprod Med 1994; 39:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/89\">",
"      Court DJ, Mann SL, Stone PR, et al. Comparison of glucose polymer and glucose for screening and tolerance tests in pregnancy. Obstet Gynecol 1985; 66:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/90\">",
"      Bergus GR, Murphy NJ. Screening for gestational diabetes mellitus: comparison of a glucose polymer and a glucose monomer test beverage. J Am Board Fam Pract 1992; 5:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/91\">",
"      Reece EA, Holford T, Tuck S, et al. Screening for gestational diabetes: one-hour carbohydrate tolerance test performed by a virtually tasteless polymer of glucose. Am J Obstet Gynecol 1987; 156:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/92\">",
"      Guelinckx I, Devlieger R, Vansant G. Reproductive outcome after bariatric surgery: a critical review. Hum Reprod Update 2009; 15:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/93\">",
"      Posner NA, Silverstone FA, Breuer J, Heller M. Simplifying the intravenous glucose tolerance test. J Reprod Med 1982; 27:633.",
"     </a>",
"    </li>",
"    <li>",
"     Carpenter, MN. Testing for gestational diabetes. In: Diabetes in women, 3rd, Reece, EA, Coustan, DR, Gabbe, SG (Eds), Lippincott, Williams and Wilkins, Philadelphia 2004. p.211.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/95\">",
"      SILVERSTONE FA, SOLOMONS E, RUBRICIUS J. The rapid intravenous glucose tolerance test in pregnancy. J Clin Invest 1961; 40:2180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/96\">",
"      Silverstone FA, Posner NA, Pomerance W, et al. Application of the intravenous and oral glucose tolerance tests in pregnancy. Diabetes 1971; 20:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/97\">",
"      Bevier WC, Fischer R, Jovanovic L. Treatment of women with an abnormal glucose challenge test (but a normal oral glucose tolerance test) decreases the prevalence of macrosomia. Am J Perinatol 1999; 16:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/98\">",
"      Radder JK, van Roosmalen J. HbA1c in healthy, pregnant women. Neth J Med 2005; 63:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/63/9210/abstract/99\">",
"      Lowe LP, Metzger BE, Dyer AR, et al. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations of maternal A1C and glucose with pregnancy outcomes. Diabetes Care 2012; 35:574.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6797 Version 23.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-88.81.100.162-98C84763DB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_63_9210=[""].join("\n");
var outline_f8_63_9210=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1818764\">",
"      Classic definition of gestational diabetes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7111897\">",
"      IADPSG definitions for overt and gestational diabetes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      - Overt diabetes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Gestational diabetes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1819068\">",
"      PREVALENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      SIGNIFICANCE OF DIABETES IN PREGNANCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      RISK FACTORS FOR DIABETES DURING PREGNANCY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Approaches to reduce the risk of developing gestational diabetes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1818482\">",
"      BENEFITS AND HARMS OF SCREENING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SCREENING VERSUS DIAGNOSTIC TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3238377\">",
"      Whom to screen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      When to screen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      How to screen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3156457\">",
"      - Two step approach",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - One step approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      GLUCOSE TOLERANCE TEST",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5480965\">",
"      100 gram three hour oral glucose tolerance test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5480972\">",
"      75 gram two hour oral glucose tolerance test",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5480735\">",
"      PATIENTS UNABLE TO TOLERATE ORAL HYPEROSMOLAR GLUCOSE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3830491\">",
"      Test alternatives to the GCT and GTT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5480742\">",
"      Serial glucose monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5480749\">",
"      Intravenous GTT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5480756\">",
"      A1C",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/6797\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6797|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?2/4/2127\" title=\"algorithm 1\">",
"      IADPSG protocol for evaluation of diabetes in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6797|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/15/33019\" title=\"table 1\">",
"      Two hour GTT for GDM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/35/27198\" title=\"table 2\">",
"      Overview of diagnostic criteria for gestational diabetes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/24/8587\" title=\"table 3\">",
"      Glucose challenge test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/32/17932\" title=\"table 4\">",
"      Three hour GTT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/0/13327\" title=\"table 5\">",
"      IV GTT",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/54/38758?source=related_link\">",
"      Diagnosis of diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/18/27945?source=related_link\">",
"      Fertility and pregnancy after bariatric surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44809?source=related_link\">",
"      Infant of a diabetic mother",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/61/13274?source=related_link\">",
"      Maternal endocrine and metabolic adaptation to pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/62/37866?source=related_link\">",
"      Medical management and follow-up of gestational diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/19/20794?source=related_link\">",
"      Medical management of type 1 and type 2 diabetes mellitus in pregnant women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/13/4313?source=related_link\">",
"      Obstetrical management of pregnancies complicated by gestational diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/62/35818?source=related_link\">",
"      Obstetrical management of pregnancy complicated by pregestational diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/46/12002?source=related_link\">",
"      Patient information: Gestational diabetes (diabetes that starts during pregnancy) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?32/13/32979?source=related_link\">",
"      Patient information: Gestational diabetes mellitus (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29162?source=related_link\">",
"      Prediction and prevention of type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/27/36281?source=related_link\">",
"      Pregnancy risks in women with type 1 and type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/11/29882?source=related_link\">",
"      The impact of obesity on fertility and pregnancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_63_9211="Western blot diagnosis of Lyme";
var content_f8_63_9211=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F50882&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F50882&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Criteria for western blot diagnosis of Lyme disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Type of infection",
"      </td>",
"      <td class=\"subtitle1\">",
"       Isotype",
"      </td>",
"      <td class=\"subtitle1\">",
"       Bands to be considered",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       First few weeks",
"      </td>",
"      <td>",
"       IgM",
"      </td>",
"      <td>",
"       Two of the following: ospC (24), 39, 41",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       After first few weeks",
"      </td>",
"      <td>",
"       IgG",
"      </td>",
"      <td>",
"       Five of the following: 18, 23, 28, 30, 39, 41, 45, 58,66, 93",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     Criteria for positive western blot (immunoblot) analysis in the serologic confirmation of infection with Borrelia burgdorferi (Lyme disease).",
"    </div>",
"    <div class=\"reference\">",
"     Criteria derived from Dressler, F, Whalen, JA, Reinhardt BN, Steere AC, J Infect Dis 1993; 167:392. *Alternate criteria for IgM reactivity, proposed by a Centers for Disease Control and Prevention conference. Other points noted at that conference were the need for standardization of the antigen preparation and techniques used.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_63_9211=[""].join("\n");
var outline_f8_63_9211=null;
var title_f8_63_9212="Grade GVHD by organ system";
var content_f8_63_9212=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F68233&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F68233&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Severity of acute graft-versus-host-disease by organ system",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"10%\">",
"     </colgroup>",
"     <colgroup width=\"80%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Organ",
"       </td>",
"       <td class=\"subtitle1\">",
"        Grade",
"       </td>",
"       <td class=\"subtitle1\">",
"        Description",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        Skin",
"       </td>",
"       <td class=\"centered\">",
"        +1",
"       </td>",
"       <td>",
"        Maculopapular rash over &lt;25 percent of body area",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        +2",
"       </td>",
"       <td>",
"        Maculopapular rash over 25 to 50 percent of body area",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        +3",
"       </td>",
"       <td>",
"        Generalized erythroderma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        +4",
"       </td>",
"       <td>",
"        Generalized erythroderma with bullous formation and often with desquamation",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        Liver",
"       </td>",
"       <td class=\"centered\">",
"        +1",
"       </td>",
"       <td>",
"        Bilirubin 2.0 to 3.0 mg/dL; SGOT 150 to 750 IU",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        +2",
"       </td>",
"       <td>",
"        Bilirubin 3.1 to 6.0 mg/dL",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        +3",
"       </td>",
"       <td>",
"        Bilirubin 6.1 to 15.0 mg/dL",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        +4",
"       </td>",
"       <td>",
"        Bilirubin &gt;15.0 mg/dL",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        Gut",
"       </td>",
"       <td class=\"centered\">",
"        +1",
"       </td>",
"       <td>",
"        Diarrhea &gt;30 mL/kg or &gt;500 mL/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        +2",
"       </td>",
"       <td>",
"        Diarrhea &gt;60 mL/kg or &gt;1000 mL/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        +3",
"       </td>",
"       <td>",
"        Diarrhea &gt;90 mL/kg or &gt;1500 mL/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        +4",
"       </td>",
"       <td>",
"        Diarrhea &gt;90 mL/kg or &gt;2000 mL/day; or severe abdominal pain with or without ileus",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_63_9212=[""].join("\n");
var outline_f8_63_9212=null;
var title_f8_63_9213="C neoformans india ink";
var content_f8_63_9213=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F63752&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F63752&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cryptococcus neoformans in an India ink preparation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    India ink preparation of cerebrospinal fluid (x400) shows a prominent clear zone around individual yeasts, consistent with the capsule of Cryptococcus neoformans. The yeast in the center of the slide is budding.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_63_9213=[""].join("\n");
var outline_f8_63_9213=null;
var title_f8_63_9214="Proposed genetic testing algorithm for pts with PCC or PGL";
var content_f8_63_9214=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F86406&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F86406&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Proposed genetic testing algorithm for patients with pheochromocytoma/paraganglioma based on clinical features",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 438px; height: 318px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Proposed genetic testing algorithm for patients with&nbsp;paraganglioma based upon the clinical features of the tumor(s). Genes are listed after descending priority from top to bottom.",
"    <div class=\"footnotes\">",
"     <p>",
"      <em>",
"       VHL",
"      </em>",
"      : von Hippel-Lindau gene;",
"      <em>",
"       NF1",
"      </em>",
"      : Neurofibromatosis type&nbsp;1 gene;",
"      <em>",
"       SDHX",
"      </em>",
"      : Succinate dehydrogenase complex genes;",
"      <em>",
"       SDHA",
"      </em>",
"      : Succinate dehydrogenase subunit A gene;",
"      <em>",
"       SDHB",
"      </em>",
"      : Succinate dehydrogenase subunit&nbsp;B gene;",
"      <em>",
"       SDHC:",
"      </em>",
"      Succinate dehydrogenase subunit&nbsp;C gene;",
"      <em>",
"       SDHD",
"      </em>",
"      : Succinate dehydrogenase subunit&nbsp;D gene;",
"      <em>",
"       SDHAF2",
"      </em>",
"      : SDH complex assembly factor2 gene;",
"      <em>",
"       MAX",
"      </em>",
"      : MYC-associated factor X gene.",
"     </p>",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      &nbsp;",
"     </p>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_63_9214=[""].join("\n");
var outline_f8_63_9214=null;
var title_f8_63_9215="RP Tracheal stenosis CT";
var content_f8_63_9215=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F58373&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F58373&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Relapsing polychondritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 260px; height: 434px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiplanar computed tomographic reformatting of the trachea demonstrates a long segment stenosis involving the entire trachea.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_63_9215=[""].join("\n");
var outline_f8_63_9215=null;
